bims-micgli Biomed News
on Microglia
Issue of 2026–08–16
79 papers selected by
Matheus Garcia Fragas, Universidade de São Paulo



  1. Front Immunol. 2026 ;17 1893545
      Triggering receptor expressed on myeloid cells 2 (TREM2) plays a crucial role in regulating microglial function in Alzheimer's disease (AD) and other neurodegenerative disorders. Genetic studies have identified rare coding variants in TREM2 as significant risk factors for late-onset AD (LOAD), highlighting the importance of disrupted microglial signaling in disease pathogenesis. Biochemically, TREM2 acts as a receptor for lipid- and damage-associated molecular patterns, recognizing anionic phospholipids, myelin-derived lipids, apolipoproteins, and aggregated amyloid-β (Aβ). It engages with adaptors like DAP12 and DAP10, activating key signaling pathways, including SYK, PI3K-AKT-mTOR, and PLCγ2, leading to microglial transcriptional and metabolic reprogramming. These processes are essential for the transition of microglia to disease-associated microglia (DAM), influencing amyloid plaque compaction and tau pathology propagation. This review aims to synthesize the latest insights into TREM2 biology, focusing on the role of TREM2 in microglial state transitions, lipid metabolism, and myelin turnover. It also examines the pathophysiological relevance of soluble TREM2 (sTREM2) and AD-associated TREM2 variants. Furthermore, the review explores the therapeutic potential of targeting TREM2, including strategies based on agonistic antibodies and modulation of receptor shedding. Beyond prior descriptive summaries, we organize these findings within a stage-resolved immunometabolic framework that links disease timing, lipid-stress context, and microglial state transitions. This framework is intended to explain why similar TREM2-directed interventions may yield different outcomes across disease stages and pathology compositions. We further highlight stage-specific translational logic, including biomarker-informed (e.g., sTREM2-guided) stratification and monitoring, to support testable and clinically actionable trial designs.
    Keywords:  Alzheimer’s disease; TREM2; lipid metabolism; microglia; therapeutic targeting
    DOI:  https://doi.org/10.3389/fimmu.2026.1893545
  2. Glia. 2026 Oct;74(10): e70207
      Microglia are innate immune cells of the central nervous system (CNS). They extend their processes and migrate toward injuries in vivo. However, how the fractalkine receptor (CX3CR1) influences microglial migration remains unknown. Label-free proteomic profiling predicted changes in Ras homology family (RHO)-signaling activity that hint at dysregulated cytoskeleton signaling in Cx3cr1-deficient murine cortex tissue. To further investigate microglial migration, we carried out two-photon in vivo imaging at 4-h intervals for 72 h after a laser lesion in the cortex. Cx3cr1-deficient microglia showed enhanced migration toward the lesion. Additionally, the length and velocity of microglial fine processes extending toward the lesion were increased in Cx3cr1-deficient microglia. Migration remained unchanged in Ccr2-deficient mice, indicating that monocyte-derived macrophages/microglia did not contribute to microglia accumulation around the lesion. These results demonstrate that CX3CR1 modulates microglia migration toward laser-induced CNS injury. Manipulating microglia migration via the CX3CR1 signaling axis is therefore a potential target for the treatment of CNS injury.
    Keywords:  CX3CR1; cytoskeleton; microglia; migration
    DOI:  https://doi.org/10.1002/glia.70207
  3. Aging Cell. 2026 Aug;25(8): e70660
      Microglia, the resident macrophages of the central nervous system (CNS), are key players in maintaining brain and spinal cord homeostasis and protecting the CNS from damage and disease. During aging, the brain undergoes profound changes-including chronic low-grade inflammation, synaptic dysfunction, and increased vulnerability to neurodegenerative diseases-all of which are closely related to alterations in microglial function. One emerging theme is that microglial metabolism is a crucial determinant of their immune and homeostatic activity. In this mini-review, we explore how metabolic programs shape brain microglial behavior and how these processes change during aging and in neurodegenerative diseases. We first highlight the link between specific metabolic pathways and key microglial functions, including phagocytosis, cytokine production, and the oxidative stress response. We then discuss how microglial metabolism is reprogrammed during healthy aging and in Alzheimer's disease and Parkinson's disease, including sex-specific differences. Finally, we examine regulators that influence microglial metabolic states and discuss how these pathways contribute to disease susceptibility and progression. Collectively, recent findings highlight the central role of metabolic reprogramming in shaping microglial responses during aging and in neurodegenerative diseases. We emphasize the need for integrative studies that consider microglial subsets, sex differences, disease context, and upstream molecular regulators to better understand how microglial metabolism contributes to brain health and pathology. A deeper understanding of these pathways may offer new opportunities for therapeutic strategies aimed at restoring microglial homeostasis and mitigating harmful neuroinflammatory processes.
    Keywords:  Alzheimer's disease; Parkinson's disease; brain aging; metabolism; microglia; neuroinflammation; sex differences
    DOI:  https://doi.org/10.1111/acel.70660
  4. Immunity. 2026 Aug 11. pii: S1074-7613(26)00315-8. [Epub ahead of print]59(8): 2055-2057
      Genetic associations point to a connection between lysosomal function and neurodegeneration. In this issue of Immunity, Balak et al. and Tejwani et al. show that genetically distinct lysosomal insults converge on a shared MITF/TFE-driven epigenetic program that underlies disease-associated microglial states, thereby connecting lysosomal dysfunction with transcriptional regulation in microglia.
    DOI:  https://doi.org/10.1016/j.immuni.2026.07.016
  5. Nat Commun. 2026 Aug 12. pii: 8173. [Epub ahead of print]17(1):
      There is little understanding of how aging serves as the strongest risk factor for several neurodegenerative diseases. Microglia undergo age-related maladaptive changes, including increased inflammation, impaired debris clearance, and cellular senescence, yet specific mediators that regulate these processes remain unclear. The aged brain is rejuvenated by youth-associated plasma factors, including tissue inhibitor of metalloproteinases 2 (TIMP2), which we have shown acts on the extracellular matrix (ECM) to regulate synaptic plasticity. Given emerging roles for microglia in these processes, we examined the impact of TIMP2 on microglial function. We show that TIMP2 deletion in mice exacerbates microglial phenotypes associated with aging, including transcriptomic changes in cell activation, changes in lysosomal-associated markers and phagocytosis, and elevated levels of stress and inflammatory proteins in the brain extracellular space measured by in vivo microdialysis. Deleting specific cellular pools of TIMP2 in vivo increases microglial CD68 and alters myelin phagocytosis. Treating aged mice with TIMP2 reverses several phenotypes observed in our deletion models, resulting in decreased microglial activation, reduced proportions of proinflammatory microglia, and enhanced phagocytosis of physiological substrates. Our results identify TIMP2 as a modulator of age-associated microglia dysfunction. Harnessing its activity may mitigate detrimental effects of age-associated insults on microglia function.
    DOI:  https://doi.org/10.1038/s41467-026-74906-z
  6. Cell Metab. 2026 Aug 04. pii: S1550-4131(26)00223-8. [Epub ahead of print]38(8): 1524-1526
      In this issue of Cell Metabolism, Adler et al.1 demonstrate that microglia coordinate multicellular metabolic interactions within the neurovascular niche. They identify microglia-derived cysteine-rich angiogenic inducer 61 (CYR61) as a mediator promoting cerebral glucose uptake and neuronal protein synthesis, thereby highlighting a role for microglia in supporting neuronal adaptation on demand.
    DOI:  https://doi.org/10.1016/j.cmet.2026.05.013
  7. Aging Cell. 2026 Aug;25(8): e70653
      Microglia, the brain's resident immune cells, are transcriptionally diverse and highly dynamic, but during aging and disease they lose their transcriptomic flexibility and adopt a chronically activated state that is associated with neuroinflammation and pathology. An emerging transcriptomic process that is also increasingly implicated in brain aging, neuroinflammation, and disease is the dysregulation of transposable elements (TEs), repetitive genomic sequences with the potential to cause cellular stress/dysfunction. However, there are limited data on microglial TE transcript patterns in these contexts. Here, we analyzed multiple RNA-seq datasets from isolated human and mouse microglia across aging, Alzheimer's disease (AD), and AD-associated pathology. In contrast to previous observations based on whole-brain tissue and other brain cell types, we found that microglial TE transcript levels remained relatively consistent throughout most of the human lifespan before increasing in late life. We also found that TE transcript levels in microglia from AD patients showed minimal changes compared to age-matched controls, and in RNA-seq analyses of transgenic AD mouse models we observed pathology-associated TE transcript decreases. Subsequent analyses identified inverse associations between TE transcript levels and autophagy/lysosome-related gene expression, and in vitro studies suggested that aging- and AD-relevant stimuli, as well as pharmacological autophagy inhibition, modulate TE transcript expression in cultured human microglia. Together, these data provide novel insight into TE transcript dynamics in microglia, highlighting TE transcript patterns that differ from those observed in whole-brain samples and other cell types in aging and AD.
    DOI:  https://doi.org/10.1111/acel.70653
  8. Biomed Pharmacother. 2026 Aug 08. pii: S0753-3322(26)00877-2. [Epub ahead of print]202 119841
      Microglia are central regulators of the cellular phase of Alzheimer's disease (AD). Under chronic exposure to amyloid-β, pathological tau, and aging-associated bioenergetic decline, these cells undergo immunometabolic remodeling that may initially be adaptive. As stress persists, this remodeling can become maladaptive, marked by disordered glycolysis, disturbed lipid handling, mitochondrial dysfunction, and compensatory failure. In this review, we organize these changes as a stage-dependent trajectory from adaptive remodeling to functional decompensation. We introduce the "metabolic paradox" as an operational descriptor: a concurrent, same-cell mismatch between increased substrate uptake or inflammatory activation and declining bioenergetic efficiency and homeostatic function. Along this trajectory we examine neurovascular energy bottlenecks, substrate redistribution, triggering receptor expressed on myeloid cells 2 (TREM2)/apolipoprotein E (APOE)-dependent lipid homeostasis, mitochondrial and proteostatic collapse, and their links to persistent neuroinflammation, defective phagocytosis, aberrant synaptic pruning, and senescence-like dysfunction. We synthesize prior primary findings and stratify each major claim by evidentiary strength, avoiding the overinterpretation of model-specific results as patient-level mechanisms. Finally, we frame immunoprevention as mechanism-based, early-stage metabolic intervention to preserve homeostatic microglial function, a strategy whose clinical benefit remains a hypothesis requiring prospective testing.
    Keywords:  Alzheimer’s disease; Glycolysis; Immunometabolism; Lipid metabolism; Microglia
    DOI:  https://doi.org/10.1016/j.biopha.2026.119841
  9. Alzheimers Dement. 2026 Aug;22(8): e71742
       INTRODUCTION: Alzheimer's disease (AD) features amyloid beta (Aβ) plaques and tau tangles, yet how their coexistence reshapes brain transcriptomic programs remains unclear.
    METHODS: We performed high-quality, sex-balanced single-nucleus RNA sequencing of 5XFAD (Aβ), PS19 (tau), and combined 5XFAD;PS19 mice.
    RESULTS: We identified transcriptional programs that emerged most prominently under combined pathology. These programs included disruption of glial lipid metabolism and immune pathways at the network level, alongside immune and synaptic alterations coordinated between microglia and oligodendrocytes. Cross-species analyses further revealed that the pathway-level alterations under combined pathology, particularly in immune, lipid, and cell cycle programs, exhibited the strongest concordance with human AD datasets, underscoring their translational relevance.
    DISCUSSION: Beyond benchmarking mouse models, this study provides a high-quality transcriptomic resource to dissect multicellular disease mechanisms in AD and to prioritize therapeutic targets for a network-level systems pharmacology approach.
    Keywords:  5XFAD;PS19 mouse model; Accelerating Medicines Partnership Program for Alzheimer's Disease; Alzheimer's disease; amyloid beta; cross‐species alignment; neurodegeneration; single‐nucleus RNA sequencing; tau; transcriptome
    DOI:  https://doi.org/10.1002/alz.71742
  10. Cell Signal. 2026 Aug 13. pii: S0898-6568(26)00473-0. [Epub ahead of print]148 112815
      Impaired myelin integrity and defective myelin regeneration represent core pathological features shared by central nervous system (CNS) diseases, such as multiple sclerosis (MS), Alzheimer's disease (AD), ischemic cerebral white matter lesions and spinal cord injury (SCI). Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is highly enriched in central resident microglia; it is also expressed by border-associated macrophages and lesion-infiltrating monocyte-derived macrophages, rather than being restricted to parenchymal microglia, acting as a key membrane receptor regulating microglial immune balance, lipid transport, lysosomal degradation and cell polarization. Existing studies demonstrate that TREM2 binds various ligands including myelin lipid debris, apolipoprotein E (APOE) and apoptotic cell components, then activates multiple DNAX-activating protein of 12 kDa (DAP12)-dependent signaling cascades: spleen tyrosine kinase (SYK)-phosphatidylinositol 3-kinase (PI3K), phospholipase C gamma 2 (PLCγ2), beta-catenin and transcription factor EB (TFEB). These pathways jointly clear myelin debris, remodel cholesterol circulation, restrain pro-inflammatory microenvironment and promote oligodendrocyte precursor cell (OPCs) differentiation, exerting bidirectional functions in physiological myelin homeostasis, acute injury response and chronic repair. This narrative review summarizes TREM2's gene and protein structure, ligand recognition modes and full signal transduction network. It illustrates the molecular mechanisms of TREM2 in myelin maintenance, debris clearance and regeneration, compares its distinct pathological roles in various demyelinating diseases, and concludes translational strategies including TREM2 agonism, downstream pathway intervention and biomarker exploitation. Furthermore, this narrative review analyzes unsolved core scientific issues and puts forward research routes for mechanistic research and clinical transformation, offering systematic theoretical basis for targeted drug development against demyelinating encephalopathies.
    Keywords:  Demyelinating diseases; Microglia; Myelin; Myelin regeneration; Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
    DOI:  https://doi.org/10.1016/j.cellsig.2026.112815
  11. Neuron. 2026 Aug 11. pii: S0896-6273(26)00577-5. [Epub ahead of print]
      Aging is the major risk factor for neurodegenerative disease, yet the mechanisms linking physiological aging to brain dysfunction remain unclear. We investigated the brains of telomere-shortened mice and observed lipofuscinosis, hypomyelination, microglial atrophy, and cognitive deficits. Single-nucleus RNA sequencing (snRNA-seq) revealed accelerated glial aging and elevated microglial senescence pathways. In a senescence model of human induced pluripotent stem cell (iPSC)-derived microglia, delta-like non-canonical Notch ligand 1 (DLK1) was identified as a novel senescence-associated ligand. Soluble DLK1 (sDLK1) was increased in the cerebrospinal fluid of telomere-shortened and naturally aged mice, and this increase was eliminated by microglial depletion. In vivo elevation of sDLK1 caused hypomyelination and blocked oligodendrocyte lineage progression, and these effects demonstrate the detrimental nature of excessive sDLK1. In human iPSC systems, sDLK1 impaired oligodendrocyte maturation and altered calcium signaling in excitatory neurons. These findings identify microglial senescence as a core consequence of telomere shortening and reveal sDLK1 as a microglia-derived senescence ligand that drives oligodendrocyte and neuronal dysfunction in aging.
    Keywords:  DLK1; SASP; microglia; neuronal activity; oligodendrocyte; senescence; telomere erosion
    DOI:  https://doi.org/10.1016/j.neuron.2026.07.021
  12. Sci Adv. 2026 Aug 14. 12(33): eaec9180
      The mouse epidermis harbors two key resident immune populations-dendritic epidermal T cells (DETCs), a subset of invariant γδ T cells, and Langerhans cells (LCs), specialized tissue-resident macrophages-both of which play critical roles in immune surveillance, barrier integrity, and tissue homeostasis. While their fetal origin has been defined, the mechanisms governing their postnatal maturation remain poorly understood. Here, we present a combined immunophenotypic and single-cell transcriptomic map of DETC and LC development from late embryogenesis through adulthood in mice. We delineate distinct differentiation trajectories characterized by dynamic changes in morphology, proliferation, and transcriptional programming. Using γδ T cell deficient mice, we show that LC maturation proceeds independently of canonical γδDETCs, likely due to compensatory αβDETCs. Analysis of germfree mice and wildlings further demonstrates that the postnatal DETC and LC differentiation is independent of microbial colonization. Comparative analysis with developing human epidermis reveals partially conserved differentiation programs. Together, our findings define core principles underlying establishment of the epidermal immune niche.
    DOI:  https://doi.org/10.1126/sciadv.aec9180
  13. Acta Neuropathol. 2026 Aug 08. pii: 17. [Epub ahead of print]152(1):
      Histopathologic staging models of neuronal α-synuclein pathology (n-asyn) in Lewy body disease (LBD) seldom evaluate brain regions with direct synaptic connectivity to model the role of microglial processes. We address this gap by testing the hypothesis that, within the well-defined synaptic connectivity of the intrahippocampal circuit, n-asyn is associated with activated microglial phenotypes. We selected a cohort of autopsy-confirmed LBD patients and minimal age-related copathologies (n = 62) and a control cohort of cognitively healthy patients with isolated hippocampal tau accumulation (i.e., primary age-related tauopathy, PART; n = 12), to control for neurodegenerative pathology without amyloid plaques. We immunostained consecutive hippocampal sections for n-asyn and established markers of activated microglial phenotypes, Iba1, HLA-DR, and CD68. With validated digital histology methods, we measured percent area occupied (%AO) of each marker in 6 hippocampal subfields to compare and correlate microglial morphologic and proteomic activation phenotypes between cohorts and used linear mixed effects models to compare the %AO between subfields while covariying for demographics. We also constructed groups of n-asyn restricted to the cornu ammonis (CA) 2-3 subfields (Focal Subtype) or widespread n-asyn within additional subfields (Widespread Subtype) to model hypothesized n-asyn spread within the intrahippocampal circuit. LBD patients exhibited increased HLA-DR and CD68%AO in most hippocampal subfields compared with PART. In LBD patients, all microglial markers were the highest in the CA2. CA2 n-asyn correlated with HLA-DR and CD68 but not Iba1%AO. Patients classified as Widespread Subtype had worse cognitive impairment and increased CA2 HLA-DR and CD68%AO. CA2 HLA-DR and CD68%AO correlated with distal n-asyn in retrograde, but not anterograde connected subfields. Our data show that activated microglial phenotypes in the CA2 of LBD patients are associated with worse clinical outcomes and retrograde n-asyn transmission. These data suggest that measures of microglial states can refine LBD histopathological progression models.
    Keywords:  Hippocampus; Lewy body dementia; Lewy body disease; Lewy pathology; Microglia; α-Synuclein
    DOI:  https://doi.org/10.1007/s00401-026-03065-8
  14. Cell Rep. 2026 Aug 08. pii: S2211-1247(26)00881-8. [Epub ahead of print]45(8): 117803
      Astrocytes and APOE are strongly implicated in Alzheimer's disease (AD), yet the impact of astrocytes carrying different APOE variants on AD hallmarks remains incompletely understood. Here, we generate a chimeric model of AD by transplanting isogenic APOE3 or APOE4 human induced pluripotent stem cell-derived astrocyte progenitors into neonatal AD mice. Donor cells differentiate into human astrocytes that integrate into the cortex and display morphologies consistent with interlaminar-like astrocytes. APOE3 and APOE4 astrocytes differ in expression of APOE, which associates differentially with Aβ plaques. Notably, APOE3 astrocytes are associated with reduced Aβ burden, Tau pathology, and neuritic dystrophy, whereas APOE4 astrocytes exacerbate these processes. They also induce distinct microglial responses: APOE4 astrocytes enhance microglial clustering around Aβ plaques and promote a disease-associated microglia-like state, whereas APOE3 astrocytes reduce clustering and support a more homeostatic profile. These findings highlight a role for human astrocytes and APOE-dependent astrocyte functions in modulating AD-related pathology.
    Keywords:  AD; APOE; Alzheimer's disease; Aβ; CP: neuroscience; CP: stem cell research; amyloid-beta; apolipoprotein E; chimeric mice; hAstrocytes; hiPSCs; human astrocytes; human induced pluripotent stem cells
    DOI:  https://doi.org/10.1016/j.celrep.2026.117803
  15. Cell Rep. 2026 Aug 10. pii: S2211-1247(26)00873-9. [Epub ahead of print]45(8): 117795
      Microglia, embryonically derived tissue-resident macrophages of the central nervous system, are essential for brain development, homeostasis, and disease. Although transforming growth factor β (TGF-β) signaling is required for mammalian microglia ontogeny, its precise role and evolutionary conservation remain unclear. Using zebrafish as a vertebrate in vivo model, we find Tgf-β receptor signaling as a conserved, cell-intrinsic regulator of microglial differentiation. Pharmacological or genetic disruption of Tgf-β receptor function arrests microglial development after progenitor migration to the embryonic neuroepithelium, preventing activation of the microglial gene expression program. Genetic rescue experiments demonstrate a direct requirement for Tgf-β receptor signaling within the myeloid lineage. We identify Tgf-β1 as the key ligand driving this process and show that sustained signaling is required to maintain microglial identity. Adult zebrafish microglia, whose origin differs from that in mice, similarly fail to differentiate without Tgf-β signaling. Together, these findings establish an evolutionarily conserved TGF-β signaling axis that instructs and maintains microglial identity in vivo.
    Keywords:  CP: developmental biology; CP: neuroscience; differentiation; hematopoiesis; macrophages; microglia; ontogeny; signaling; transforming growth factor-β; zebrafish
    DOI:  https://doi.org/10.1016/j.celrep.2026.117795
  16. Nat Neurosci. 2026 Aug 13.
      In Alzheimer's disease, the protein tau is thought to redistribute from axons to the somatodendritic compartment and form fibrillar aggregates. Although tau aggregation is a hallmark of Alzheimer's disease, the dynamics of its synthesis and degradation are not well characterized. Given that nascent polypeptides are particularly susceptible to misfolding, local control of tau synthesis and degradation may be essential to prevent aggregation. Here we develop STARFISH, a method for visualizing the subcellular site of endogenous mRNA translation in primary neurons and in vivo with single-molecule sensitivity and near-codon resolution, without modifying the nascent polypeptide. Using STARFISH, we show that despite the broad distribution of Mapt mRNA, tau is translated exclusively in neuronal dendrites. About one-third of newly synthesized tau is co-translationally or peri-translationally degraded in dendrites by a neuronal-specific plasma-membrane-associated proteasome, the neuroproteasome. Failure of neuroproteasome-mediated degradation leads to the protein synthesis-dependent accumulation of somatodendritically mislocalized endogenous tau aggregates. These findings define a proteostasis mechanism that counterbalances the constitutive physiological overproduction of tau. We speculate that failure of this proteostasis system contributes to tau aggregation in dendrites in Alzheimer's disease.
    DOI:  https://doi.org/10.1038/s41593-026-02398-7
  17. Alzheimers Dement. 2026 Aug;22(8): e71738
    Dominantly Inherited Alzheimer Network
       INTRODUCTION: An extra copy of the amyloid precursor protein (APP) gene causes autosomal dominant Alzheimer's disease (AD) and AD in Down syndrome (DS), but the factors underlying variability in age at onset (AAO) remain unclear. We investigated whether sporadic AD risk variants modify AAO.
    METHODS: We analyzed clinical and genetic data from 100 APP duplication (APPdup) carriers and 957 individuals with DS. Cox models assessed associations of apolipoprotein E (APOE) ε2 and ε4 and the AD genetic risk score (AD-GRS; excluding APOE and chromosome 21 variants) with AAO.
    RESULTS: Mean AAO was earlier in APPdup than DS (51 ± 7 vs. 53 ± 6 years; P = 0.0005). APOE ε2 delayed onset (hazard ratio [HR] = 0.47, P < 0.0001), whereas APOE ε4 (HR = 1.5, P = 0.0003) and higher AD-GRS (HR = 1.3 per standard deviation, P < 0.0001) accelerated onset. Predicted median AAO differed by 10 years between lowest and highest genetic risk.
    DISCUSSION: Sporadic AD genetic risk factors are important modifiers of AAO in APPdup and DS, explaining part of the marked variability in onset.
    Keywords:  Alzheimer's disease; Down syndrome; Down syndrome‐associated Alzheimer's disease; amyloid precursor protein duplication; apolipoprotein E; autosomal dominant Alzheimer's disease; disease onset; polygenic risk score
    DOI:  https://doi.org/10.1002/alz.71738
  18. Neurosci Bull. 2026 Aug 08.
      Patients with Alzheimer's disease (AD) frequently experience inflammatory insults; however, the mechanisms by which microglia respond to these challenges remain unclear. Although AD microglia have been proposed to be primed for exaggerated inflammatory responses, single-cell evidence remains limited. To investigate microglial responses to inflammation in AD, we challenged AD mouse models with intraperitoneal lipopolysaccharide (LPS) and used single-cell RNA sequencing to characterize microglial states, along with in vivo immunostaining and in vitro models to define their features and underlying mechanisms. We found that, in response to an inflammatory challenge, microglia adopted a low-inflammatory state accompanied by elevated expression of mitochondrial respiratory chain genes. This state was associated with the phagocytosis of dystrophic neurites and was recapitulated in vitro using an efferocytosis-based model, with apolipoprotein E implicated in its underlying mechanism. In summary, we identified a distinct microglial state that provides new insights into the dynamic role of microglia in AD.
    Keywords:  Alzheimer’s disease; Apolipoprotein E; Dystrophic neurites; Microglia priming; Systemic inflammation
    DOI:  https://doi.org/10.1007/s12264-026-01693-4
  19. Cell. 2026 Aug 14. pii: S0092-8674(26)00875-5. [Epub ahead of print]
      Brain perivascular macrophages maintain brain physiology, yet their transcriptional regulators and functions in health and disease remain unclear. Using single-cell multi-omics and functional experiments, we identify cellular musculoaponeurotic fibrosarcoma oncogene (cMAF) as a key transcription factor for brain perivascular macrophages, and conditional deletion of cMAF disrupts their phenotype in vivo. Functionally, cMAF drives insulin-like growth factor-1 (IGF1) expression in perivascular macrophages, enabling communication with endothelial cells. Consistently, cMAF deletion in perivascular macrophages causes transcriptional alterations in cerebral arteries, affecting vascular functions. Notably, cMAF emerges as the main transcription factor for human perivascular macrophages, suggesting conservation of this transcriptional module. During Alzheimer's disease (AD), human perivascular macrophages upregulate cMAF and IGF1 to enhance communication with vascular cells, and this response is abrogated in APOE4 carriers. Lastly, we explore an uncharacterized polymorphism in cMAF, providing evidence that the cMAF program is protective against AD. Targeting cMAF in perivascular macrophages may offer new therapeutic strategies for neurodegenerative and cerebrovascular diseases.
    Keywords:  APOE4; Alzheimer's disease; IGF1; arteries; cMAF; cerebral blood flow; cerebrospinal fluid; immune-vascular axis; microglia; perivascular macrophages
    DOI:  https://doi.org/10.1016/j.cell.2026.07.043
  20. Brain Behav Immun. 2026 Aug 10. pii: S0889-1591(26)00701-4. [Epub ahead of print] 106953
      Metabolic dysfunction in microglia is increasingly recognized as a core driver of Alzheimer's disease (AD) pathogenesis, and yet the underlying mechanisms remain elusive. Here, we identified salt-inducible kinase 2 (SIK2) as a critical metabolic checkpoint that was downregulated in microglia across the AD mouse models (5 × FAD, APP/PS1, and SAMP8). We found that a loss of SIK2 in microglia induced a pro‑inflammatory phenotype, thus impairing amyloid β-protein (Aβ) phagocytosis and rewiring glucose and lipid metabolism toward enhanced glycolysis and lipid accumulation. Mechanistically, SIK2 directly interacted with the histone acetyltransferase P300; SIK2 deficiency increased the activity of P300, elevating H3K9 acetylation and H4K8/12 lactylation at promoters of metabolic genes. The microglia‑specific SIK2 overexpression in the 5 × FAD mice mitigated cognitive deficits, Aβ pathology, neuroinflammation, and aberrant histone modifications. A pharmacological inhibition of P300 regained these protective effects. Our findings highlight the SIK2-P300 epigenetic axis as a key regulator of the metabolic homeostasis in microglia and a potential therapeutic target for AD treatments.
    Keywords:  Acetylation; Alzheimer’sdisease; Lactylation; Metabolic reprogramming; Neuroinflammation; P300; Salt-inducible kinase 2
    DOI:  https://doi.org/10.1016/j.bbi.2026.106953
  21. CNS Neurosci Ther. 2026 Aug;32(8): e71073
       AIMS: Cerebral ischemic stroke triggers extensive neuronal membrane breakdown, releasing a massive load of cholesterol that overwhelms resident microglia. Dysregulated microglial cholesterol metabolism has been implicated in post-stroke neuroinflammation, yet the specific pathogenic microglial subpopulations, their molecular signatures, and the downstream inflammatory cascades remain poorly defined.
    METHODS: We employed a permanent distal middle cerebral artery occlusion (dMCAO) model combined with single-cell RNA sequencing (scRNA-seq) to profile immune cell transcriptomes and identify cholesterol-associated microglial markers. Cholesterol dynamics, lipid droplet accumulation, and inflammatory marker expression were quantified via immunofluorescence and transmission electron microscopy. Therapeutic interventions included pharmacological cholesterol mobilization with 2-hydroxypropyl-β-cyclodextrin (HβCD), pharmacological STING inhibition with C-176, and microglia-targeted STING knockdown using AAV9 vectors. Cerebral injury and neurological function were assessed through infarct volume measurement, white matter integrity analysis, and behavioral assays (rotarod and grip strength) in dMCAO, tMCAO, and perioperative stroke (PIS) models.
    RESULTS: Using scRNA-seq, we identified interferon-induced transmembrane protein 3 (IFITM3) as a specific marker for a microglial subpopulation that was characterized by upregulated ACAT1, enhanced cholesterol esterification, and accumulation of cholesterol crystals and lipid droplets. This IFITM3+ microglia population peaked at 7 days post-stroke and correlated with NLRP3 inflammasome activation and STING signaling. Pharmacological reduction of cholesterol burden with HβCD attenuated lipid droplet formation, suppressed mitochondrial DNA leakage, and inhibited STING pathway activation. Correspondingly, HβCD and C-176 administration significantly reduced cerebral infarct size, mitigated white matter demyelination, and improved motor function in dMCAO and tMCAO models. We further found that AAV-mediated STING knockdown recapitulated the above protective effects in HβCD and C-176 treated stroke mice. Furthermore, HβCD treatment ameliorated microglial inflammation and improved functional outcomes in a PIS model.
    CONCLUSION: IFITM3+ microglia is a pro-inflammatory and cholesterol-laden subpopulation that exacerbates post-stroke cerebral ischemic brain injury. Targeting the microglial cholesterol axis by HβCD or inhibiting the STING pathway represents a promising therapeutic strategy to mitigate ischemic brain injury and improve neurological function.
    Keywords:  STING; cholesterol; ischemic stroke; microglia; neuroinflammation
    DOI:  https://doi.org/10.1002/cns.71073
  22. Nat Genet. 2026 Aug 14.
      We developed a high-content screening to investigate how Alzheimer's disease (AD) genetic risk factors may affect synaptic mechanisms in rat primary neuronal cultures. Of the target genes identified, we found that Plcg2 downregulation in mouse dentate gyrus neurons consistently disrupted dendritic morphology and synaptic function. In human neuronal cultures (hNCs), PLCG2 downregulation also impaired synaptic function and increased amyloid-β (Aβ) levels and Tau phosphorylation. Very rare PLCG2 loss-of-function (LoF) variants were associated with a tenfold increased AD risk. PLCG2 LoF carriers show low mRNA/protein PLCG2/PLCγ2 levels and the R953* LoF mutation compromised synaptic function and increased AD hallmarks in hNCs. Single-nucleus RNA sequencing analyses confirmed that the downregulation of PLCG2 impacted pathways related to synaptic and neuronal functions, potentially through neurexins in neurons. In conclusion, PLCγ2 downregulation could increase AD risk by impairing synaptic functions and by increasing Aβ levels and Tau phosphorylation in neurons.
    DOI:  https://doi.org/10.1038/s41588-026-02709-5
  23. Front Cell Neurosci. 2026 ;20 1931155
      
    Keywords:  Alzheimer's disease; Parkinson's disease; T cells; microglia; neuroimmune interaction; neuroinflammation; post-ischemic neurodegeneration
    DOI:  https://doi.org/10.3389/fncel.2026.1931155
  24. Front Immunol. 2026 ;17 1843165
      Epilepsy affects around 70 million people worldwide, and roughly one-third of them respond poorly to standard antiepileptic drugs. Current treatments are directed almost entirely at neurons, leaving the contribution of non-neuronal cells largely unaddressed. Microglia, the resident immune cells of the central nervous system, both support neuronal survival and shape neural circuits by pruning synapses through "eat-me" and "don't-eat-me" signals. In epilepsy, this pruning becomes dysregulated: microglia preferentially eliminate inhibitory synapses, producing excitatory/inhibitory (E/I) imbalance, synchronized network discharges, and a lowered seizure threshold. This review summarizes recent work on pathological synaptic pruning by microglia in epilepsy, focusing on the signaling pathways that drive the process and on whether they can be targeted therapeutically in drug-resistant epilepsy. The broader goal is to suggest new treatment directions beyond conventional, neuron-targeted pharmacology.
    Keywords:  complement inhibitor; don’t-eat-me signal; eat-me signal; seizures; synaptic plasticity; treatment
    DOI:  https://doi.org/10.3389/fimmu.2026.1843165
  25. Nat Genet. 2026 Aug 11.
      Myeloid cells, including microglia and perivascular macrophages, are central to Alzheimer's disease (AD) neurobiology, yet their role remains incompletely understood. We profiled 832,505 human myeloid cells from the prefrontal cortex of 1,607 donors spanning the lifespan and showing varying degrees of AD neuropathology. We delineated six subclasses comprising 13 transcriptionally distinct subtypes and identified adaptive changes associated with aging and AD progression. Here we show that a disease-associated microglial subtype, characterized by elevated GPNMB expression and enriched for polygenic AD risk, expands with AD pathology and shows increased phagocytic activity. We identify MITF as an upstream regulator required to maintain this microglial state. Cell-cell interaction analyses prioritize APOE-SORL1 and APOE-TREM2 signaling pairs associated with disease progression. Using human and mouse models, we demonstrate that the neuroprotective effects of this microglial subtype depend on TREM2. These findings provide mechanistic insights into myeloid cell function in aging and AD, aiding therapeutic discovery.
    DOI:  https://doi.org/10.1038/s41588-026-02716-6
  26. Curr Neuropharmacol. 2026 Jul 28.
       OBJECTIVE: Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily involving the loss of dopaminergic neurons and pathological α-synuclein (α-syn) aggregation. A pivotal feature of PD pathogenesis is the dual role of microglia, which shifts from maintaining neuronal homeostasis to driving neuroinflammation and neurodegeneration. The mechanisms underlying this functional transition and its consequences for disease progression require a comprehensive synthesis.
    METHODS: A structured PubMed search was performed using the keywords "Parkinson's disease", "microglia", "neuroinflammation", "α-synuclein", "polarization", "tunneling nanotubes (TNTs)", "NF-κB", and "NLRP3". Relevant combinations of these terms were also used. A total of 2952 records were retrieved up to December 2025. Of these, 147 studies were included based on relevance to microglial polarization, neuroinflammation, α-syn-related pathology, and intercellular communication mechanisms.
    RESULTS: In early PD stages, microglia exert neuroprotective effects by transferring excess neuronal α-syn via TNTs, delivering healthy mitochondria, and clearing α-syn through autophagy. With disease progression, accumulated α-syn promotes microglial polarization toward the M1 phenotype. This shift activates TLR2/4, TREM2, MHCII, and RAGE receptors, triggering NF-κB/NLRP3 pathways, releasing pro-inflammatory cytokines, and generating NOX2-derived ROS. The resulting neuroinflammatory cascade not only damages dopaminergic neurons directly but also disrupts astrocyte function and blood-brain barrier integrity, creating a self-perpetuating cycle of inflammation and neurodegeneration.
    DISCUSSION: These findings support dysregulated microglial polarization as an important component of PD pathobiology, but the available evidence remains weighted toward preclinical models. Future work should better define the timing, heterogeneity, and clinical measurability of microglial state transitions before microglia-targeted strategies can be translated with confidence.
    CONCLUSION: Microglial polarization may represent a potential therapeutic direction in Parkinson's disease, although further mechanistic and clinical validation and more precise biomarker definition remain necessary.
    Keywords:  Parkinson's disease; ROS; microglia; neuroinflammation; α-syn
    DOI:  https://doi.org/10.2174/011570159X473857260708102204
  27. Proc Natl Acad Sci U S A. 2026 Aug 18. 123(33): e2537768123
      Diffuse midline gliomas (DMGs) are highly aggressive, WHO grade 4 glial tumors that arise in midline central nervous system structures and are defined by K27M mutations in histone H3 genes. These K27M mutations shape intratumoral myeloid cell composition in DMG. In H3.1K27M DMGs, genetic ablation of monocyte recruitment reshapes the tumor microenvironment (TME) by reducing monocyte-derived macrophages (MDMs) and increasing microglia and neutrophil presence, with overall survival remaining unchanged, indicating compensatory myeloid remodeling is occurring. Here, by using CRISPR/Cas9-based genome editing, we generated a mouse model deficient for CCR1/CCR2/CCR3/CCR5 (Δ1235). Using this strain, we effectively abolished monocyte and MDM infiltration and reversed compensatory recruitment of CCR1+ neutrophils. Abolishing MDMs in tumors skewed remaining neutrophils and microglia toward a homeostatic state, reduced expression of immune checkpoint molecules on T cells, and extended the survival of H3.1K27M DMG-bearing mice. In contrast, H3.3K27M DMG showed independence from MDM recruitment, suggesting reliance on other TME-driven signaling. Last, H3.1K27M DMGs exhibited reduced microglia presence and a dose-dependent increase in MDM infiltration postirradiation. MDM depletion did not further enhance radiation efficacy, potentially due to compensatory recruitment of classical neutrophils. Collectively, these data reveal histone mutation-specific myeloid dependencies in DMG, highlighting MDM-independent mechanisms in H3.3K27M tumors and MDM-dependent pathways in H3.1K27M tumors.
    Keywords:  Glioma; microglia; monocyte; neutrophil; pediatric
    DOI:  https://doi.org/10.1073/pnas.2537768123
  28. J Vis Exp. 2026 Jul 24.
      Microglia are myeloid-derived immune cells of the central nervous system that mediate tissue degradation and remodeling following neurological injury and have emerged as promising therapeutic targets in several neurodegenerative diseases. Quantitative analysis of microglial morphology can reveal subtle differences among microglial subpopulations while preserving important in situ information. However, many currently available microglial morphology analysis platforms are either not publicly accessible or require specialized computational expertise, thereby limiting their widespread adoption. To address these limitations, an open-source microglial morphology analysis platform, termed Mapping Microglial Parameters Software (MMPS), using Python 3.11 was developed. MMPS is compatible with immunofluorescence-based workflows and requires no coding expertise for installation or operation. The software semi-automates single-cell microglial morphology analysis through an accessible graphical user interface and incorporates customizable image-processing and mask-generation workflows. The study involves validating MMPS using a rodent lipopolysaccharide (LPS)-induced neuroinflammation model. Quantitative animal-level analysis demonstrated that microglia from LPS-treated animals exhibited significantly increased soma area (p < 0.01) and reduced cell perimeter (p < 0.05) compared with vehicle-treated controls, consistent with morphological features associated with microglial activation and neuroinflammation. Overall, MMPS provides a standardized, reproducible platform for quantitative analysis of microglial morphology across laboratories.
    DOI:  https://doi.org/10.3791/71566
  29. Front Cell Neurosci. 2026 ;20 1886995
       Introduction: Impaired microglial clearance of amyloid-β (Aβ) is a central driver of Alzheimer's disease (AD), yet the mechanisms governing intracellular Aβ degradation remain poorly defined.
    Methods: We investigated the role of CD22 in microglial Aβ processing using primary microglia, transcriptomic profiling, and hippocampal samples from AD patients and transgenic mice.
    Results: We identified CD22 as an Aβ-inducible signaling regulator that restrains microglial Aβ processing. CD22 expression was elevated in the hippocampus of AD patients and transgenic mice and was rapidly induced by Aβ in microglia. Functionally, CD22 knockdown enhanced intracellular Aβ degradation without affecting initial uptake. Transcriptomic profiling identified the AD risk gene INPP5D as a key downstream effector of CD22. Loss of CD22 suppressed INPP5D expression and promoted AKT activation, while INPP5D overexpression partially rescued the enhanced Aβ clearance phenotype. These findings define a CD22-INPP5D signaling axis that acts as a molecular brake on microglial Aβ processing. Aβ itself induces CD22 expression, revealing a feed-forward inhibitory loop in which amyloid accumulation limits its own clearance.
    Discussion: Collectively, these findings identify a regulatory mechanism controlling intracellular Aβ degradation and suggest the CD22-INPP5D axis as a potential therapeutic target for AD.
    Keywords:  Alzheimer's disease; Aβ clearance; CD22; INPP5D; primary microglia
    DOI:  https://doi.org/10.3389/fncel.2026.1886995
  30. J Vis Exp. 2026 Jul 24.
      As the resident immune cells of the central nervous system, microglia are central regulators of brain homeostasis and key mediators of neurodegenerative disease. These cells continuously survey the neural environment and play a critical role in the recognition, internalization, and degradation of extracellular substrates, including misfolded and aggregated proteins such as pathological tau. Despite growing evidence implicating microglia in tau clearance, existing approaches to measure tau uptake and degradation lack the temporal resolution and sensitivity needed to fully capture these dynamic processes. Here, we developed a luminescence-based assay to quantitatively monitor tau clearance in human induced pluripotent stem cell (iPSC)-derived microglia. This platform leverages a split-luciferase-based complementation system to enable highly sensitive, real-time detection of tau in live cells, allowing for precise tracking of its intracellular processing. This assay is scalable and adaptable across multiple cell types, providing a versatile tool to interrogate endolysosomal pathways and cellular mechanisms governing tau handling in neurodegenerative diseases, including Alzheimer's disease.
    DOI:  https://doi.org/10.3791/71870
  31. Sci Immunol. 2026 Aug 14. 11(122): eadv9397
      Host-derived lipids undergoing enzymatic or nonenzymatic oxidation play critical roles in regulating inflammation. Polyunsaturated fatty acids, cholesterol, and cholesterol intermediates can be enzymatically oxidized and serve as signaling mediators controlling tissue homeostasis and immunity. Spontaneously generated oxidized lipids, including nonenzymatically oxidized phospholipids (oxPLs), result from oxidative stress and accumulate during inflammation, affecting cellular metabolism, immune cell functions, and cell fate. These distinct classes of oxidized lipids not only share overlapping inflammatory roles but also exhibit divergent effects depending on their molecular structures and cellular targets. This Review highlights the double-edged nature of oxPLs: Although their transient production triggers protective responses, their accumulation sustains inflammation, contributing to tissue damage. We also discuss the emerging roles of oxPLs in cell death programs, immune cell activation, and stromal cell functions, which are critical processes favoring tumor growth. Overall, we highlight how oxidized lipids orchestrate immune responses and explore their contribution to infectious diseases and cancer.
    DOI:  https://doi.org/10.1126/sciimmunol.adv9397
  32. Curr Opin Pharmacol. 2026 Jul 20. pii: S1471-4892(26)00046-9. [Epub ahead of print]90 102650
      Alzheimer's disease (AD) is increasingly recognized as a disorder involving interacting neuroimmune, glial, vascular, and synaptic processes that are not fully captured by single-pathway therapeutic models. Although anti-amyloid monoclonal antibodies slow clinical progression in selected early amyloid-positive patients, their benefit remains stage-dependent, monitoring-intensive, and incomplete with respect to downstream neural dysfunction. Clinically, vulnerable older adults may show abrupt cognitive decline after pneumonia-related hospitalization or other severe infections. This observation raises a pharmacological question: whether infection-triggered peripheral immune events activate modifiable risk processes before they become sustained neuroimmune and synaptic dysfunction. NETosis is one candidate mechanism linking peripheral inflammatory stress to endothelial injury, blood-brain barrier vulnerability, myeloid priming, and microglial dysregulation. Acute infection may represent a high-intensity peripheral NETosis-related trigger, whereas periodontitis provides a chronic, low-grade, neutrophil-rich, microbially driven, clinically measurable, and modifiable peripheral inflammatory model. We propose a node-based pharmacological framework organized around NETosis-associated immune amplification, microglial state dysregulation, and synaptic vulnerability. Selected phytochemicals are examined as node-aligned pharmacological probes rather than validated AD therapeutics: baicalin and hesperidin for NETosis-associated immune amplification, berberine for microglial state modulation, and catalpol as a synapse-proximal candidate.
    DOI:  https://doi.org/10.1016/j.coph.2026.102650
  33. Cell. 2026 Aug 04. pii: S0092-8674(26)00821-4. [Epub ahead of print]
      Cortical development involves rapid progenitor expansion and cell diversification supported by tightly regulated metabolic programs, yet these programs remain largely uncharacterized in human development. Here, we generated a metabolic atlas of the early human cortex using primary tissue and stem cell-derived cortical organoids. We observed dynamic changes in core metabolic functions, including an unexpected increase in glycolysis and pentose phosphate pathway (PPP) activity during late neurogenesis. Manipulation of glucose availability in cortical organoids altered cell-type composition, increasing outer radial glia (oRG) and inhibitory neuron populations. Pharmacological and genetic inhibition of PPP enzymes recapitulated these cell fate changes. Ribose was sufficient to rescue radial glia (RG) gene expression changes, revert organoid cell-type composition, and restore levels of ATP and hypotaurine. These data identify a critical role for the PPP in modulating RG cell fate specification and generate a resource for future exploration of additional metabolic pathways in human cortical development.
    Keywords:  cell fate; cortical development; cortical organoids; glycolysis; metabolism; metabolomics; neurodevelopment; pentose phosphate pathway; radial glia
    DOI:  https://doi.org/10.1016/j.cell.2026.07.023
  34. Sci Adv. 2026 Aug 14. 12(33): eaec3842
      Myasthenia gravis (MG) presents a clinical challenge where autoantibody titers poorly predict disease severity, and thymectomy provides inconsistent benefits. We hypothesized that thymic B cells acquire survival mechanisms that bypass canonical tolerance checkpoints, enabling persistence independent of antigen-specific selection. Using single-cell RNA sequencing, V(D)J repertoire analysis, and spatial transcriptomics to generate the largest MG atlas to date (237,661 cells), we identified a tolerance checkpoint swap in MG pathogenesis. Pathological class-switched B cells within thymic germinal centers exhibited reduced antigen presentation (CD74 and CD1C) and diminished CD40 costimulation while up-regulating TNFRSF17 to engage BAFF-driven survival. This shift allows polyclonal autoreactive B cells to evade stringent selection and seed peripheral sites. T follicular helper cells supported this reprogramming via increased TNFSF13B and CHGB expression, with the latter facilitating dopamine-mediated synaptic acceleration. These findings offer insight into clinical paradoxes in MG and point to the BAFF-BCMA axis as a potential therapeutic target and biomarkers for disease activity.
    DOI:  https://doi.org/10.1126/sciadv.aec3842
  35. Neurotoxicology. 2026 Aug 11. pii: S0161-813X(26)00166-X. [Epub ahead of print]116 103545
      Bisphenol A (BPA), a ubiquitous environmental contaminant, is increasingly recognized as a neurotoxicant. Epidemiological and experimental evidence links BPA exposure with neurodegenerative diseases and abnormal neurobehavior, implicating it as a risk factor for neuronal dysfunction and cognitive impairment. Given the critical role of microglia in maintaining brain immune homeostasis, we investigated whether BPA interfered with microglial immune reactivity, which may be one of the reasons why BPA causes neuropathological alterations. Using an in vitro BV-2 microglial model, sublethal BPA exposure, with or without lipopolysaccharide (LPS), was assessed for immunoinflammatory responses. BPA, without compromising cell viability, suppressed basal immune activity and attenuated LPS-induced responses. This was evidenced by reduced secretion of pro- and anti-inflammatory cytokines, alterations in NLRP3 inflammasome-related signaling (including caspase-1 and IL-1β processing), and dysregulated expression of antioxidants, motility-related proteins, and zinc-dependent metalloproteinases. These changes were associated with downregulation of MAPK, Akt, and NF-κB pathways, alongside ROS-dependent upregulation of the Nrf2-Keap1/heme oxygenase-1 (HO-1) axis, which interfered with both quiescent and LPS-driven Toll-like receptor 4 (TLR4) signaling. Collectively, these findings suggest that sublethal BPA interferes with TLR4-related immunoinflammatory signaling in microglia, potentially via modulation of the ROS/Nrf2-Keap1/HO-1 axis. Given that disruption of brain innate immunity may elevate the risk of developing neuropathies, this work highlights the potential impact of BPA, particularly on microglial immune function.
    Keywords:  Bisphenol A; Heme oxygenase-1; Inflammation; Microglia; Neuroimmunity; Toll-like receptor 4
    DOI:  https://doi.org/10.1016/j.neuro.2026.103545
  36. J Mol Neurosci. 2026 Aug 10. pii: 127. [Epub ahead of print]76(3):
      Extracellular ATP is a central danger signal linking cellular stress to neuroinflammation, yet the mechanisms governing the transition from physiological purinergic signaling to pathological neuroimmune activation remain incompletely understood. In this review, we integrate current evidence into a conceptual framework describing how ATP-dependent purinergic signaling may contribute to the shift from adaptive neuron-glia communication to maladaptive glial crosstalk and inflammatory amplification. Under physiological conditions, controlled ATP turnover primarily engages lower-threshold purinergic pathways, including P2X4-mediated signaling that supports microglial surveillance, synaptic remodeling, and tissue homeostasis. In contrast, sustained extracellular ATP accumulation during injury, oxidative stress, or impaired ATP clearance preferentially recruits the low-affinity P2X7 receptor, triggering ionic dysregulation, Ca²⁺ influx, and redox-sensitive signaling pathways that promote NF-κB activation and NLRP3 inflammasome assembly. We further examine how receptor crosstalk, particularly with TLR4 and emerging redox regulatory mechanisms involving protein disulfide isomerase (PDI), may influence P2X7 signaling across different neuroinflammatory contexts. Finally, we discuss current evidence for therapeutic targeting of P2X7, highlighting translational challenges related to blood-brain barrier penetration, receptor occupancy, disease stage, and patient selection. By integrating recent advances in purinergic, redox, and neuroimmune signaling, this review provides a heuristic framework for understanding context-dependent P2X7 activation while distinguishing established mechanisms from emerging concepts that require further experimental validation.
    Keywords:  Inflammasome; Microglia; Neuroinflammation; P2X7 receptor; Purinergic signaling; Redox regulation
    DOI:  https://doi.org/10.1007/s12031-026-02581-2
  37. Neurochem Res. 2026 Aug 08. pii: 235. [Epub ahead of print]51(4):
      Activation of microglia and inflammatory response play a central role in the pathological process following intracerebral hemorrhage (ICH). In this study, single-nucleus transcriptomic and proteomic profiling was performed to investigate microglial changes after ICH. A significant upregulation of complement receptor C5aR1 was identified, particularly enriched in microglial subsets exhibiting a pro-inflammatory phenotype. The cellular localization and temporal expression dynamics of C5aR1 were validated by immunofluorescence staining, Western blotting, and quantitative PCR, demonstrating its sustained elevation in microglia after ICH. Pharmacological inhibition with the selective C5aR1 antagonist PMX205 markedly reduced the release of inflammatory cytokines, alleviated neuronal damage, and improved neurological function. Proteomic profiling and subsequent validation suggested that CCR5 may be associated with C5aR1-related inflammatory responses after ICH. Collectively, these findings suggest that C5aR1 serves as a regulatory factor in microglia-mediated neuroinflammation following ICH, and that targeting this pathway may offer a promising therapeutic strategy for hemorrhagic stroke.
    Keywords:  C5aR1; Intracerebral hemorrhage; Microglia; Neuroinflammation; PMX205
    DOI:  https://doi.org/10.1007/s11064-026-04858-9
  38. Parasite Immunol. 2026 Aug;48(8): e70096
      Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) peptide accumulation and tau protein-mediated neurodegeneration, and neuroinflammation is increasingly recognized as a major process associated with tau pathology. Chronic Toxoplasma gondii infection reduces amyloid accumulation in AD models through immune modulation, but its stage-specific associations with tau-related pathology remain unclear. Here, we investigated how chronic T. gondii infection is associated with tau-related molecular and neuropathological changes in the 5XFAD AD mouse model. At 40 weeks post-infection, we profiled transcriptomic changes and evaluated Aβ-associated (21 genes), Aβ/tau-shared (22 genes), and tau-associated (21 genes) pathological programs together with p-tau immunoreactivity in brain sections. Chronic infection was associated with selective modulation of molecular networks linked to neuroimmune signalling and tau-related pathways rather than broad suppression of AD-related gene expression. Among tau-related pathological stages, the neuroinflammation-related amplification module linking Aβ and tau exhibited the most prominent transcriptomic change in T. gondii-infected AD mice, whereas upstream kinase-related initiation pathways and downstream toxin conversion or accumulation-related processes changed relatively minimally. These transcriptomic changes were accompanied by a marked reduction in phosphorylated tau load at the tissue level. Collectively, these findings suggest that chronic T. gondii infection is associated with selective modulation of tau-related pathogenic programs and reduced p-tau burden in the 5XFAD brain.
    Keywords:   Toxoplasma gondii ; 5XFAD mouse model; Alzheimer's disease; immune modulation; neuroinflammation; tau pathology; transcriptomics
    DOI:  https://doi.org/10.1111/pim.70096
  39. Int J Mol Sci. 2026 Aug 05. pii: 7034. [Epub ahead of print]27(15):
      Autoreactive lymphocytes are thought to contribute to tissue injury in the pathogenesis of multiple sclerosis (MS). However, reliable biomarkers reflecting myelin-specific immune responses and disease activity remain limited. In HLA-DRB1*15:01-positive individuals, the myelin basic protein (MBP) epitope MBP85-99 represents a well-characterized immunodominant target of CD4+ T cells. Using classical spectratyping, we characterized the peripheral T-cell receptor (TCR) β-chain repertoire reactive to MBP85-99 in individuals with MS, according to their HLA-DRB1 haplotypes. Selected rearrangements were further evaluated in cerebrospinal fluid (CSF), cytokine-defined T-cell subsets, and longitudinal samples collected during interferon beta-1a treatment. A restricted set of shared ("public") MBP85-99-reactive TCR rearrangements was identified in individuals with MS and differed from the repertoire observed in healthy controls. These TCRs were more frequently detected during periods of active disease than during remission. Two disease-associated public rearrangements were enriched in active MS, whereas one rearrangement was preferentially observed in healthy controls. HLA-DRB1*15:01-restricted MBP85-99-specific public TCR signatures were associated with inflammatory disease activity in MS and may help distinguish pathogenic from non-pathogenic autoreactive responses. In a longitudinal sub-cohort (n = 15, ~10-year follow-up), the RSI of the principal disease-associated rearrangement TRBV19-TRBJ2.4 correlated positively with cumulative relapse burden (Spearman ρ = 0.782, p = 0.002), providing preliminary evidence that these TCR signatures reflect long-term inflammatory disease activity. These findings support further validation of antigen-specific TCR profiling as a biomarker strategy in MS using contemporary high-throughput immune repertoire technologies.
    Keywords:  T-cell receptor repertoire; antigen-specific immunity; immune biomarkers; immunogenetics; neuroinflammation
    DOI:  https://doi.org/10.3390/ijms27157034
  40. Mol Biol Rep. 2026 Aug 13. pii: 1396. [Epub ahead of print]53(1):
      Amyloid-beta (Aβ) plaque formation and tauopathy are two of several hallmarks of Alzheimer's disease (AD), a neurodegenerative disease. AD's widely known pathological hallmarks include extracellular amyloid-β deposition, neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein, synaptic dysfunction, neuroinflammation, and cognitive decline. These pathological hallmarks can be explained at the neurochemical level as a loss of biochemical homeostasis in the brain. Dysregulated kinase-phosphatase signalling, altered post-translational modifications, and disrupted synaptic neurochemistry eventually push tau protein towards its pathological aggregation-prone form. Among these hallmarks, recent research has found that tau pathology plays a major role in neurodegeneration and cognitive decline. Tau protein typically acts as a microtubule-stabilizing protein that helps maintain neuronal structure. In AD, pathological hyperphosphorylation, post-translational modifications, and redistribution of tau trigger its dysfunction and cytotoxicity. Pathological tau protein accumulates in neurons and undergoes a series of changes that include hyperphosphorylation, aberrant post-translational modifications, missorting, aggregation, fibrillization, and seeding as it spreads between cells. Mutations in APP, PSEN1, and PSEN2 can have downstream effects on tau pathology. Variants in APOE, BIN1, PICALM, CD2AP, and TREM2 also influence tau pathology through cellular pathways including lipid metabolism, endocytic trafficking, proteostasis, and synaptic and neuroimmune mechanisms. These findings support a model in which tau dysfunction results from the convergence of molecular aberrations and genetic susceptibility within a pathological network involving amyloid-β, neuroinflammation, and synaptic failure. This review summarizes tau molecular and cellular mechanisms of tau dysfunction in AD, genetic factors regulating tau pathology, and emerging therapeutic approaches to mitigate tau-mediated neurodegeneration.
    Keywords:  Alzheimer’s disease; MAPT; Neurofibrillary tangles; Neuroinflammation; Tau pathology; Tau therapeutics
    DOI:  https://doi.org/10.1007/s11033-026-12578-0
  41. Mol Neurobiol. 2026 Aug 08. pii: 821. [Epub ahead of print]63(1):
      The immune and inflammatory responses following ischemic stroke involve aberrant DNA exposure, immunothrombosis, and innate immune activation. Post-stroke, damage-associated DNA signals from multiple sources may activate DNA-sensing pathways; however, how DNA from distinct sources links peripheral immune activation with inflammatory amplification within the brain remains incompletely understood. Among these, neutrophil extracellular traps (NETs), as DNA-rich extracellular structures, may represent a potential link connecting vascular inflammation, immunothrombosis, and intracerebral DNA sensing. The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway, a key DNA-sensing axis, mediates distinct inflammatory and stress responses across various stroke-associated cell types. This review summarizes the mechanisms of DNA recognition, NET-mediated immunothrombosis, and neuroinflammatory damage, as well as the functional characteristics of cGAS-STING signaling in different cell types. Based on current evidence, we propose a potential NETs-cGAS-STING inflammatory amplification framework: NET-derived DNA may contribute to DNA-sensing activation within the ischemic brain and promote microglial inflammatory responses, while the resulting inflammatory factors and chemotactic signals may further promote neutrophil recruitment and secondary NET formation, thereby potentially creating a feed-forward loop linking peripheral immune activation with neuroinflammation. We further discuss the spatiotemporal heterogeneity of this axis, therapeutic targets, and challenges for clinical translation. Overall, the NETs-cGAS-STING framework provides an integrated conceptual perspective for understanding the intercellular interactions underlying DNA recognition and the sustained amplification of inflammation following stroke, and offers insights into future precision immune interventions tailored to disease stage, lesion characteristics, and cell-specific responses.
    Keywords:  DNA sensing; Ischemic stroke; Microglia; Neutrophil extracellular traps; cGAS–STING
    DOI:  https://doi.org/10.1007/s12035-026-06109-y
  42. Aging Brain. 2026 ;10 100164
      Blood-brain barrier (BBB) integrity naturally declines with age. Brain endothelial cells (ECs) and pericytes (PCs) form the BBB, and aging impairs tight junctions, likely via altered PC-to-EC signaling. However, the molecular mechanisms underlying this impairment remain unclear. Using single-cell RNA sequencing, we profiled 68,316 brain ECs expressing 15,564 genes from young and old mice. Unsupervised clustering and annotation revealed five distinct EC subtypes-Capillary EC1, Capillary EC2, Arterial EC, Venous EC1, and Venous EC2-defined by marker genes Mfsd2a, Plvap, Bmx, Nr2f2, and Vcam1, respectively. Aging shifted EC subtype distribution, with reduced Capillary EC1 (45% vs. 57%) and increased Arterial (33% vs. 16%) and Venous ECs (12% vs. 2%) compared with young mice. Mio analysis further showed that Capillary EC1 and Venous EC2 neighborhoods were less abundant in aged brains. Biotin metabolism was decreased in old vs. young mice, particularly within Capillary EC1, Capillary EC2, and Arterial EC. Although widespread gene downregulation was observed across EC subsets, overall expression trends were largely consistent among clusters. Key genes-Ramp2, Hbb-bs, Ly6c1, Calm1-were less abundant, whereas Rasgrf2 was uniquely enriched in aged mice. Immunohistochemistry confirmed reduced LY6C and RAMP2 and elevated RASGRF2 in aged mouse and human brains. Cell-cell interaction analyses revealed age-associated remodeling of ligand-receptor signaling. Enrichment analyses implicated pathways involved in neurovascular integrity, inflammation, amyloid processing, and vascular remodeling. Collectively, these findings show that aging reprograms EC subtype composition, gene expression, and metabolism, thereby contributing to BBB disruption and neurovascular dysfunction.
    Keywords:  Aging; Alzheimer's disease; Endothelial cell subtypes; Ramp2; Rasgrf2; scRNA-seq
    DOI:  https://doi.org/10.1016/j.nbas.2026.100164
  43. Cell Metab. 2026 Aug 04. pii: S1550-4131(26)00192-0. [Epub ahead of print]38(8): 1527-1528
      Metabolic dysfunction is a defining but poorly understood feature of Alzheimer's disease. Du et al. show that a brain-penetrant GLP-1 receptor agonist rewires astrocyte-neuron metabolic coupling through lactate-driven histone lactylation, linking astrocytic glycolysis to neuronal lipid homeostasis and positioning metabolite signaling as a therapeutic axis in neurodegeneration.
    DOI:  https://doi.org/10.1016/j.cmet.2026.05.007
  44. Oxid Med Cell Longev. 2026 ;2026(1): e9948225
      Excessive iron accumulation is a pathological feature of several neurodegenerative diseases (NDDs), and a growing body of evidence suggests that ferroptosis, an iron-dependent form of regulated cell death (RCD) driven by lipid peroxidation, is implicated in their pathogenesis. Microglia, the brain's resident immune cells, buffer iron overload but become susceptible to ferroptotic death, exacerbating neuroinflammation and neuronal loss. To uncover the molecular events leading to microglial ferroptosis, we established a human microglial ferroptosis model using the HMC3 cell line. This model recapitulates core features of ferroptosis, including increased reactive oxygen species (ROS) and peroxidation of lipids at the membrane, both rescued by ferrostatin-1 (Fer-1). We used this model to perform integrated multiomic profiling and identified significant dysregulation in lipid species, notably an accumulation of sterols, including oxysterols such as 7-oxo-cholesterol, alongside the oxidation of polyunsaturated fatty acids (PUFAs) that are characteristic of ferroptosis. Transcriptomic and proteomic analyses corroborate these findings, revealing the upregulation of the mevalonate pathway and cholesterol metabolism. Importantly, the increased expression of some of these key metabolic genes was also reversed by Fer-1 treatment, indicating their role in a preferroptotic signature. Our model provides a novel platform for investigating early molecular events in microglia ferroptosis. Integrating these findings into future investigations could uncover new protective mechanisms against microglial ferroptosis to ensure homeostatic regulation of ROS levels and sterol metabolism.
    Keywords:  ferroptosis; lipid metabolism; microglia; neurodegeneration; oxidative stress
    DOI:  https://doi.org/10.1155/omcl/9948225
  45. Alzheimers Dement. 2026 Aug;22(8): e71684
       INTRODUCTION: Dysfunctional microRNAs and GABAergic interneurons are features of Alzheimer's disease (AD). The role of neuronal microRNA155 (miR155), elevated in both AD and Down syndrome (DS), remains unknown.
    METHODS: We utilized in silico analyses of published databases, MIR155-deleted and -overexpressing human induced pluripotent stem cell (hiPSC)-derived cells, cortical organoids, and amyloid beta precursor protein (APP)/PS1-miR155 knockout mouse.
    RESULTS: MIR155HG (miR155 host gene) colocalizes with APP in a neuron-specific, topologically associated domain (TAD) in chromosome 21. In human neural stem cells (NSCs), neurons, and cortical organoids, MIR155 deletion enhanced NSC proliferation and GABAergic interneuron generation. MIR155 overexpression inhibited NSC marker expression and GABAergic interneuron generation. In APP/PS1 mice, miR155 deletion induced the expansion of hippocampal NSCs and increased hippocampal GABAergic interneurons.
    DISCUSSION: Our findings, alongside the extensive studies of the role of microglial miR155 in neuroinflammation, reveal previously unrecognized miR155 roles in hippocampal NSC dynamics and GABAergic interneuron development, highlighting miR155 as a therapeutic target.
    Keywords:  Alzheimer's disease; Down syndrome; GABAergic interneurons; microRNA
    DOI:  https://doi.org/10.1002/alz.71684
  46. Cells. 2026 Jul 24. pii: 1322. [Epub ahead of print]15(15):
      Ischemic stroke remains a leading cause of death and long-term disability worldwide. Although acute reperfusion therapies have improved outcomes in selected patients, effective strategies that directly promote neurovascular repair during the subacute and chronic phases remain limited. Vascular network remodeling in the peri-infarct region is increasingly recognized as a key process supporting tissue repair, blood-brain barrier restoration, and functional recovery after stroke. Microglia, as resident immune cells of the central nervous system, undergo dynamic morphological, metabolic, and functional changes after ischemic injury and participate in inflammation, phagocytic clearance, blood-brain barrier regulation, and tissue repair. Among repair-associated microglial states, microglia with M2d-like features have attracted increasing attention because of their potential association with immunoregulation and pro-vascular repair. However, whether repair-associated microglia with M2d-like features represent a distinct and stable microglial subtype after stroke remains unresolved. In this review, we summarize current evidence linking repair-associated microglial responses to vascular network remodeling after ischemic stroke, with particular emphasis on the conceptual value of the M2d-like state. We discuss putative mechanisms involving paracrine signaling, perivascular localization, metabolic reprogramming, and extracellular vesicle-mediated communication. We also evaluate therapeutic implications, including traditional Chinese medicine, extracellular vesicle-based strategies, and nanodelivery systems. However, current therapeutic evidence does not establish that these interventions specifically induce M2d-like microglial states. We highlight the need for rigorous validation of cellular identity, spatial localization, and functional vascular outcomes. Overall, the M2d-like framework provides a candidate perspective for understanding immune-vascular coupling after stroke, but further studies integrating single-cell omics, spatial mapping, lineage tracing, and functional vascular assessment are required to define the identity and functional contribution of repair-associated microglia with M2d-like features. Method: This article is a narrative review. The relevant literature was searched in PubMed from database inception to June 2026 using combinations of the terms "ischemic stroke," "microglia," "macrophage," "vascular remodeling," "angiogenesis," "M2d," "extracellular vesicles," "traditional Chinese medicine," and "nanomedicine." Priority was given to original studies directly examining microglial or myeloid responses and vascular repair after ischemic stroke. Relevant review articles were included to provide conceptual background. Because direct evidence for M2d-like microglial responses after stroke remains limited, selected studies involving peripheral macrophages, tumor-associated macrophages, traditional Chinese medicine, extracellular vesicles, and nanomedicine were included as indirect or hypothesis-generating evidence. Evidence was interpreted according to the disease model, cellular source, and vascular outcomes examined, with stroke-specific microglial studies regarded as more directly relevant than evidence extrapolated from non-stroke or non-microglial models.
    Keywords:  M2d-like features; angiogenesis; blood–brain barrier; extracellular vesicles; ischemic stroke; neurovascular unit; repair-associated microglia; traditional Chinese medicine; vascular network remodeling
    DOI:  https://doi.org/10.3390/cells15151322
  47. Brain Behav Immun Health. 2026 Oct;56 101309
      Sepsis survivors often experience long-term cognitive and mental health impairment. We lack a clear understanding of the biological mechanisms driving impairment after sepsis and the factors that make a brain vulnerable to dysfunction after sepsis. We hypothesize that amyloid pathology, which is neuroinflammatory and accumulates with age even in cognitively normal people, is a latent risk factor for post-sepsis decline driven in part by neuroinflammation and microglial dysfunction. We induced sepsis via polymicrobial abdominal infection (cecal ligation and puncture; CLP) in young adult 5xFAD mice to model early amyloid pathology. 5xFAD CLP mice demonstrated generalized conditioned fear response and impaired cognition in the puzzle box task. Brain transcriptomics revealed persistent upregulation of neuroinflammatory pathways after resolution of the infection, with a distinct increase in 5xFAD CLP survivor mice. Complement gene expression and C3aR protein were heightened in 5xFAD mice, while C3 increased after infection. Microglial synaptic phagocytosis, a potential mechanism driving brain dysfunction after sepsis, was increased in 5xFAD CLP survivor mice 3 weeks after infection. While there was a small C3aRhigh microglial population in 5xFAD brains, the change in synaptic phagocytosis occurred in microglia with basal levels of C3aR expression. Overall, our findings suggest that early amyloid pathology synergistically heightens the behavioral change, neuroinflammation, and microglial synaptic phagocytosis caused by sepsis.
    Keywords:  Amyloid; Cognition; Complement; Microglia; Neuroinflammation; Sepsis; Sepsis-associated encephalopathy; Synaptic phagocytosis; Transcriptomics
    DOI:  https://doi.org/10.1016/j.bbih.2026.101309
  48. Alzheimers Res Ther. 2026 Aug 14. pii: 187. [Epub ahead of print]18(1):
       BACKGROUND: TAR DNA-binding protein of 43 kDa (TDP-43) is often found in the brains of patients with Alzheimer's disease (AD), where it co-occurs with amyloid β plaques and tau neurofibrillary tangles, and associates with accelerated cognitive decline and brain atrophy. TDP-43's function of repressing the inclusion of cryptic exons (CEs) during RNA splicing is compromised in AD. A single-nucleotide polymorphism (SNP) located within the CE in the UNC13A gene [rs12973192 (C > G)] is associated with higher disease risk and reduced survival in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) by weakening TDP-43 binding promoting CE inclusion.
    OBJECTIVE: To investigate the influence of the rs12973192 UNC13A CE SNP and UNC13A cryptic splicing on TDP-43 pathology, survival and cognitive impairment in AD.
    METHODS: We evaluated the UNC13A CE SNP in a cohort of 1,672 AD, including 643 AD brains with available cognitive measurements and 73 AD cases for which we measured cryptic RNA levels in the amygdala. We also evaluated a cohort of 466,517 from the UK Biobank to determine associations between the UNC13A CE SNP and dementia diagnosis.
    RESULTS: In AD, the UNC13A CE SNP associated significantly with cognitive decline, but not with TDP-43 pathology or with survival. UNC13A cryptic RNA levels in the amygdala were a better predictor of cognitive decline than the UNC13A CE SNP itself, while STMN2-another well-known CE target-exhibited no such association.
    CONCLUSIONS: These findings point to UNC13A cryptic splicing as a specific driver of cognitive decline in AD, outperforming both genetic risk and other cryptic targets.
    Keywords:  Alzheimer’s disease; Cognition; Cryptic exons; Dementia; STMN2; UNC13A
    DOI:  https://doi.org/10.1186/s13195-026-02157-7
  49. Adv Sci (Weinh). 2026 Aug 13. e77117
      Spinal cord injury (SCI) induces neuroinflammation predominantly mediated by microglia, thereby establishing a detrimental milieu that impedes neurological recovery. Extracellular vesicles (EVs) derived from umbilical cord mesenchymal stem cells (UCMSCs) possess considerable therapeutic potential; however, their clinical translation is constrained by insufficient bioactivity, poor targeting specificity, and uncontrolled release kinetics. Here, we present a multidimensional engineering strategy that overcomes these barriers synergistically. Tetramethylpyrazine (TMP)-pretreated extracellular vesicles (TEVs) are enriched with anti-inflammatory and pro-regenerative factors in their cargo, while Angiopep-2 (Ang2) peptide-modified TEVs (Ang-TEVs) confer significantly enhanced microglial targeting. A reactive oxygen species (ROS)-responsive hyaluronic acid (HA)-phenylboronic acid (PBA)/polyvinyl alcohol (PVA) hydrogel serves as an intelligent depot for sustained, on-demand Ang-TEVs release at the lesion site. This construct, Ang-TEVs@Gel, demonstrated robust lesion accumulation and selective microglial uptake. It delivered miR-664a-3p, which suppressed PIK3CA to attenuate PI3K-AKT-mTOR signaling and unleash autophagic flux, reprogramming microglia toward a reparative state that enhanced myelin debris clearance and quelled inflammation. Consequently, axonal regeneration and remyelination were markedly improved, driving significant motor recovery in SCI mice. By integrating preconditioning, active targeting, and stimuli-responsive biomaterials, this strategy provides an elegant blueprint for engineering EV-based therapies to repair the injured central nervous system.
    Keywords:  mesenchymal stem cell; microglia; neuroinflammation; remyelination; spinal cord injury
    DOI:  https://doi.org/10.1002/advs.77117
  50. Proc Natl Acad Sci U S A. 2026 08 18. 123(33): e2619797123
      Parkinson's disease is characterized by dopaminergic neuron loss and accumulation of α-synuclein aggregates in the brain. G51D α-synuclein knock-in mice provide a genetically and clinically relevant model of disease, exhibiting early olfactory deficits, age-dependent motor impairment, and progressive phospho-α-synuclein accumulation. In multiple Parkinson's disease models, striatal cholinergic and parvalbumin interneurons, as well as astrocytes, lose primary cilia and the neurotrophic signaling needed to sustain dopaminergic neurons. We show here that G51D α-synuclein mice share these phenotypes. Phospho-Ser129 α-synuclein accumulation correlates with cilia loss in cholinergic interneurons but not in spiny projection neurons that accumulate higher phospho-α-synuclein levels. In the piriform cortex, parvalbumin neurons lose primary cilia and downregulate Neurturin, potentially contributing to olfactory dysfunction. Within the peripheral olfactory epithelium, horizontal basal cells lose cilia, whereas multiciliated olfactory sensory neuron cilia remain intact. These findings reveal convergent cellular vulnerabilities across Parkinson's disease models and highlight a pathogenic role for impaired ciliary signaling.
    Keywords:  Parkinson’s disease; alpha-Synuclein; neurotrophic signaling; primary cilia
    DOI:  https://doi.org/10.1073/pnas.2619797123
  51. Mol Neurobiol. 2026 Aug 13. pii: 831. [Epub ahead of print]63(1):
      GPR84 is a medium-chain fatty acid (MCFA)-sensing G-protein-coupled receptor conditionally expressed on innate immune cells - neutrophils, monocytes, macrophages, and microglia - with expression strongly induced by inflammatory stimuli. Upon activation, GPR84 engages Gi/o signalling, MAPK/ERK, NF-κB, and NLRP3 inflammasome pathways, amplifying pro-inflammatory effector functions across peripheral and central myeloid populations. In microglia, receptor upregulation marks a disease-associated subpopulation linked to TNF-α and IL-1β production in models of neurodegeneration, traumatic CNS injury, and neuropathic pain. Yet the same receptor exhibits context-dependent protective roles: GPR84 deletion attenuates neuropathic hypersensitivity through peripheral macrophage reprogramming while leaving microglial activation intact, and Gpr84-deficient Alzheimer's disease mice show reduced microgliosis but paradoxically accelerated cognitive decline, demonstrating that the receptor's output is determined by cell type, disease stage, and local inflammatory context rather than by a fixed pro-inflammatory identity. Recent cryo-EM structural resolution of GPR84 has enabled the design of G-protein-biased agonists that preferentially engage pathways linked to motility and phagocytosis while sparing cytokine amplification, providing a rationale for selectively enhancing homeostatic clearance without exacerbating chronic inflammation. However, the most clinically advanced antagonist, GLPG1205, failed to meet primary endpoints in Phase II trials in ulcerative colitis and idiopathic pulmonary fibrosis. This review argues that these translational failures reflect deeper methodological limitations - including supraphysiological agonist concentrations, constitutive knockout models that conflate microglial and peripheral macrophage contributions, species selectivity gaps in available antagonists - that have produced conflicting preclinical evidence and impeded clinical translation. Resolving GPR84's context-dependent biology will require conditional genetic models, CNS-penetrant pharmacological tools, and integration of spatial and temporal multiomics approaches before the receptor's therapeutic potential can be meaningfully evaluated.
    Keywords:  Biased agonism; GPR84; Innate immunity; Microglia; Neuroinflammation; Neuropathic pain; Neutrophils; TBI
    DOI:  https://doi.org/10.1007/s12035-026-06132-z
  52. J Inflamm Res. 2026 ;19 629656
      Sepsis is increasingly viewed as a disorder of inflammatory, metabolic, and mitochondrial homeostasis, but the path from metabolic disturbance to regulated cell death (RCD) and organ injury remains incompletely defined. Human studies show clinically meaningful metabolic and bioenergetic heterogeneity, while experimental models link mitochondrial stress, inflammatory signaling, membrane disruption, and pathway-specific RCD to tissue dysfunction. This review asks how evidence can be moved from co-occurrence toward mechanism. We synthesize findings across systemic metabolic phenotypes, cell-intrinsic immunometabolism, mitochondrial stress, RCD execution, membrane failure, inflammatory cargo release, organ injury, and therapeutic relevance. Apoptosis has the strongest direct human support as a non-lytic route of immune-cell depletion and epithelial loss; pyroptosis, ferroptosis, necroptosis, and PANoptosis are supported mainly by sepsis-relevant models and remain context dependent. Stronger mechanistic inference requires aligned measurements of metabolic flux, mitochondrial state, RCD execution, membrane integrity, extracellular cargo, host-defense effects, and tissue outcomes within matched cellular, organ, model, and temporal contexts. This framework separates association, susceptibility, execution, inflammatory release, tissue consequence, and therapeutic relevance when interpreting links among metabolic stress, mitochondrial stress, and RCD in sepsis.
    Keywords:  immunometabolism; mitochondrial stress; organ dysfunction; oxidative stress; regulated cell death; sepsis
    DOI:  https://doi.org/10.2147/JIR.S629656
  53. EMBO J. 2026 Aug 10.
      Cytoplasmic lattices (CPLs) are filamentous assemblies essential for mammalian embryonic development. They are known to regulate organelle organization, spindle assembly, and protein homeostasis, but their molecular functions remain unclear. Here, we develop a strategy combining cryo-focused ion beam milling and cryo-electron tomography to resolve macromolecular complexes directly in mammalian embryos. Using this approach, we determine the in situ structure of cytoplasmic lattices within 6/8-cell mouse embryos at ~4.7 Å resolution. CPL filaments are built from multiple copies of at least fourteen proteins arranged into a ~4.5 MDa repeating unit. The repeat contains a central cavity that is open at the back and lined with multiple FBXW-SKP1 complexes and three modules, each containing the E2 ubiquitin-conjugating enzyme UBE2D and the E3 ligase UHRF1. We resolve two CPL states: one is consistent with a ubiquitin-charged UBE2D, where ubiquitin is held in an open, inactive conformation by binding the scaffold protein PADI6; the second lacks discernible ubiquitin density and shows structural changes compatible with ubiquitin becoming available for transfer. Our findings support a model in which CPLs function as large ubiquitin ligase assemblies during early embryonic development.
    DOI:  https://doi.org/10.1038/s44318-026-00895-w
  54. Biochem Pharmacol. 2026 Aug 10. pii: S0006-2952(26)00682-9. [Epub ahead of print]253(Pt 2): 118343
      Protein lysine lactylation has emerged as a candidate interface between metabolic stress and Alzheimer's disease (AD), but the strength of individual claims varies. This focused review evaluates whether reported histone and non-histone lactylation events meet analytical and experimental requirements for causal interpretation. Direct AD evidence is more robust for plaque-associated microglial histone H4 lysine 12 lactylation (H4K12la)-pyruvate kinase M2 (PKM2) feedback in an amyloid model. Histone H3 lysine 18 lactylation (H3K18la)-nuclear factor-κB (NF-κB) signaling is supported principally in senescent microglia and ageing or AD-related models. Human tau K331 lactylation demonstrates disease-associated occurrence but not quantitative occupancy, temporal precedence or residue-specific necessity. Amyloid precursor protein (APP) K612 lactylation provides a potentially protective mechanism supported by site-resolved identification, cellular perturbation and in vivo rescue. Histone H3 lysine 9 lactylation (H3K9la) and additional substrates remain hypothesis-generating. We distinguish putative enzymatic L-lactylation from methylglyoxal-derived D-lactoylation and define minimum standards for antibody specificity, stereochemistry, site localization, occupancy, protein abundance, cell composition, post-mortem quality, isotope tracing, genetic substitution and rescue. A four-tier framework separates extrapolated evidence, human occurrence or relevant in vivo association, site-specific AD-model mechanisms supported by intervention and rescue, and quantified, cell-resolved, residue-causal evidence independently replicated in human-relevant systems. Six experimental stages are proposed for advancing a candidate site from detection to human relevance. Current evidence supports protein lactylation as a context-dependent disease-modifying layer rather than a single upstream driver. Therapeutic development should prioritize validated sites and biomarker-defined cell states rather than indiscriminate suppression of lactate metabolism or global lactylation.
    Keywords:  Alzheimer’s disease; Amyloid precursor protein; Causal inference; Lysine lactoylation; Mass spectrometry; Protein lactylation; Tau
    DOI:  https://doi.org/10.1016/j.bcp.2026.118343
  55. Curr Opin Virol. 2026 Aug 14. pii: S1879-6257(26)00064-7. [Epub ahead of print]77 101572
      HSV-1 encephalitis (HSE) remains a devastating viral infection of the central nervous system despite effective antiviral therapy. Increasing evidence indicates that disease outcome is not determined by viral replication alone but by how innate immunity is calibrated within the brain. Studies of host susceptibility in childhood HSE have identified brain-intrinsic antiviral mechanisms, referring to central nervous system (CNS)-localized innate immune pathways that enable resident brain cells to sense and restrict HSV-1 infection, particularly TLR-dependent interferon responses, neuron-associated restriction factors, and other CNS-resident innate immune mechanisms. Host innate immune responses initially contribute to viral restriction, whereas excessive or unresolved activation can promote inflammatory amplification and long-term neurological injury. In parallel, HSV-1-mediated immune remodeling may weaken antiviral control and alter the subsequent inflammatory trajectory. Here, HSE is discussed as a dynamic immunopathological disorder in which protective innate immunity can transition into pathogenic neuroinflammation. Building upon these observations, we propose that host-directed therapeutic strategies should shift from uniform immune modulation toward stage-specific immune recalibration on the basis of viral control, antiviral competence, inflammatory persistence, and tissue repair.
    DOI:  https://doi.org/10.1016/j.coviro.2026.101572
  56. Adv Sci (Weinh). 2026 Aug 12. e77111
      Traumatic brain injury (TBI) disrupts the blood-brain barrier (BBB) and compromises endothelial function, leading to persistent neurological dysfunction. Although miR-15a/16-1 deletion has recently been shown to be neuroprotective in brain injury, the endothelial pathways mediating long-term structural and functional recovery after TBI remain unknown. Here, we demonstrate endothelial cell-specific deletion of miR-15a/16-1 is sufficient to confer neurorestoration after TBI by reducing acute BBB leakage, preserving white and gray matter integrity, and accelerating sensorimotor and cognitive recovery. Mechanistically, transcriptomic profiling identified SYNE1 as a direct downstream target of miR-15a/16-1, validated via in-silico binding prediction and 3'-UTR luciferase assays. Crucially, endothelial cell-targeted AAV-mediated knockdown of SYNE1 abrogated the neurorestorative effects of miR-15a/16-1 deletion, indicating SYNE1 is required for its function. Furthermore, single-cell RNA-seq analysis of human TBI tissue demonstrates significant downregulation of SYNE1 in endothelial cells within the contusion core relative to pericontusional endothelium. Together, these findings define a previously unrecognized miR-15a/16-1-SYNE1 axis that promotes endothelial repair after TBI, with significant translational potential.
    Keywords:  SYNE1; TBI; endothelial signaling; miR‐15a/16‐1; neurovascular recovery; white and gray matter integrity
    DOI:  https://doi.org/10.1002/advs.77111
  57. Neurochem Int. 2026 Aug 11. pii: S0197-0186(26)00125-7. [Epub ahead of print]200 106234
      Early brain injury (EBI) after subarachnoid hemorrhage (SAH) is closely associated with microglia-driven neuroinflammation, yet effective therapeutic strategies remain limited. Histone deacetylase 6 (HDAC6) has been implicated in neuroinflammatory regulation, but its role in microglial inflammatory activation after SAH remains unclear. In the present study, we investigated whether HDAC6 targeting attenuates SAH-induced EBI through modulation of microglia-associated neuroinflammation. A mouse prechiasmatic cistern blood-injection model of SAH and an Hb-stimulated primary microglia model were used to evaluate the effects of compound 13-7, an HDAC6-targeting inhibitor. We found that HDAC6 expression was significantly upregulated after SAH and was predominantly localized in microglia and neurons. Treatment with compound 13-7 increased α-tubulin acetylation in microglia, reduced brain edema, improved neurological deficits, and decreased neuronal apoptosis. In addition, compound 13-7 attenuated microglial inflammatory activation, reduced pro-inflammatory gene expression, decreased brain tissue levels of TNF-α, IFN-γ, and IL-6, and increased IL-4, IL-5, and IL-10 levels. In vitro, compound 13-7 protected neurons primarily through modulation of microglia-mediated inflammatory responses rather than by directly acting on neurons. Mechanistically, compound 13-7 reduced the p-P65/P65 ratio and suppressed NF-κB-related inflammatory gene expression in Hb-stimulated microglia. Collectively, these findings demonstrate that HDAC6 targeting attenuates SAH-induced EBI and improves neurological outcomes, at least partly by suppressing microglia-associated neuroinflammation and restoring inflammatory cytokine balance. Inhibition of NF-κB signaling may contribute to the anti-inflammatory effects of compound 13-7, highlighting HDAC6 as a potential therapeutic target for SAH-induced EBI.
    Keywords:  Early brain injury; HDAC6; Microglia; Neuroinflammation; Subarachnoid hemorrhage
    DOI:  https://doi.org/10.1016/j.neuint.2026.106234
  58. Front Immunol. 2026 ;17 1782384
      TREM2 is a cell surface receptor that plays a crucial role in regulating immune responses, particularly in myeloid cells such as macrophages, dendritic cells, and microglia. Initially studied for its involvement in neuroinflammation and neurodegenerative diseases, while recent evidence has highlighted its broader implications in cancer and various other diseases. Recent studies show that TREM2 plays an immunoprotective role prompted by central nervous system-enriched sphingolipids during GBM progression. TREM2 overexpression represses GBM and synergizes with anti-PD-1 therapy, suggesting a potential therapeutic avenue in cancer immunotherapy. This review provides a comprehensive overview of TREM2 biology, focusing on its molecular structure, signaling pathways, and functional roles in different disease contexts. In Alzheimer's disease, TREM2 mutations are associated with altered immune responses and impaired amyloid-beta clearance, suggesting a potential therapeutic target. In cancer, TREM2 contributes to immune evasion, tumor progression, and metastasis, with emerging strategies aiming to target TREM2 to enhance anti-tumor immunity. Additionally, TREM2 is implicated in a range of other conditions, including autoimmune diseases, multiple sclerosis, and Parkinson's disease, where it may regulate inflammatory responses and tissue damage. Despite promising findings, several challenges remain in understanding TREM2's complex role across diverse diseases. Future research directions include unraveling its precise mechanisms, validating its therapeutic potential, and exploring clinical interventions targeting TREM2. This review provides a comprehensive overview of TREM2 biology, synthesizing insights from recent single-cell transcriptomics and metabolic profiling. We focus on its molecular structure, complex signaling networks, and context-dependent functional roles across diverse disease landscapes.
    Keywords:  Alzheimer’s disease; TREM2; Tumor-associated macrophages; cancer immunotherapy; microglia; neuroinflammation; systems biology
    DOI:  https://doi.org/10.3389/fimmu.2026.1782384
  59. Elife. 2026 Aug 11. pii: RP108947. [Epub ahead of print]15
      Bordetella pertussis, the etiologic agent of whooping cough, remains a serious public health concern despite widespread vaccination. Improved therapeutics and vaccines are urgently needed. Host recognition of bacterial peptidoglycan (PGN), including B. pertussis extracellular PGN fragment tracheal cytotoxin (TCT) shapes the immune response to infection. Peptidoglycan recognition proteins (PGLYRPs) are a conserved innate immune family that bind bacterial PGN and are primarily known for bactericidal activity in mammals; however, their immune modulatory roles are beginning to gain appreciation. The role of PGLYRPs in mammalian host defenses to Gram-negative pathogens, such as B. pertussis, remains largely unknown. Here, using knockout mice, single-cell and bulk transcriptomics, and functional assays, we identify a dual role for PGLYRP1 in modulating host immune responses to B. pertussis. PGLYRP1 contributes to antibacterial responses and paradoxically dampens inflammatory responses and inhibits bacterial killing later in infection. Mechanistically, PGLYRP1 enhances NOD1 signaling in response to TCT while suppressing NOD2- and triggering receptor expressed on myeloid cells-1 (TREM-1)-mediated inflammatory pathways. TCT-bound PGLYRP1 selectively impairs TREM-1 activation compared to PGNs from other bacteria. These findings demonstrate that B. pertussis co-opts PGLYRP1 to alter immune signaling, revealing a novel immune evasion mechanism with implications for vaccine design and host-directed therapeutics.
    Keywords:  Bordetella pertussis; PGLYRP; PGLYRP1; infectious disease; inflammation; microbiology; peptidoglycan; pertussis
    DOI:  https://doi.org/10.7554/eLife.108947
  60. Int Rev Neurobiol. 2026 ;pii: S0074-7742(26)00024-3. [Epub ahead of print]188 363-396
      Alzheimer's Disease (AD) is becoming more widely recognized as a condition of brain energy metabolism, wherein lipid dysregulation plays a crucial, although unrecognized, role. In addition to functioning as structural elements of neuronal membranes, lipids such as phospholipids, sphingolipids, and cholesterol play a crucial role in regulating mitochondrial bioenergetics, synaptic activity, and membrane-associated signaling pathways. In AD, modifications in lipid composition, distribution, and turnover compromise membrane fluidity, disturb mitochondrial dynamics, and obstruct lipid-mediated transport of energy substrates. These alterations intensify oxidative stress, impair glucose and ketone utilization, and stimulate neuroinflammatory pathways that further diminish metabolic capacity. Progress in lipidomics has uncovered disease-specific lipid signatures, providing a fresh understanding of the relationship between lipid homeostasis and neuronal energy loss. Despite extensive focus on amyloid and tau, lipid-mediated bioenergetic failure remains underrepresented in integrative AD models; this chapter addresses this gap and consolidates existing information connecting lipid modifications to metabolic dysfunction in AD, emphasizing molecular pathways and prospective treatment strategies aimed at lipid metabolism to re-establish bioenergetic equilibrium.
    Keywords:  AD; Lipid dysregulation; Lipidomics; Mitochondrial bioenergetics; Neuroinflammation; Therapeutic strategies
    DOI:  https://doi.org/10.1016/bs.irn.2026.02.004
  61. Mol Cell Biochem. 2026 Aug 08.
      Traumatic brain injury (TBI) remains a major cause of neurological morbidity worldwide, and mild TBI (mTBI) is frequently associated with emotional disturbances, including anxiety-like behavior. Although classical mechanisms of secondary injury have been extensively characterized, metabolic alterations, particularly those involving cerebral lipid homeostasis, remain incompletely defined. Given the structural and regulatory roles of lipids in the central nervous system, disruption of lipid metabolism may contribute to early post-traumatic dysfunction. We hypothesized that mTBI induces region-specific alterations in brain lipid metabolism and that these changes are associated with anxiety-like behavior during the acute post-injury phase. Adult male C57BL/6 mice were subjected to a weight-drop model of mTBI and evaluated 48-72 h post-injury using different behavioral paradigms. Lipid classes were quantified in the hippocampus, prefrontal cortex, and serum by thin-layer chromatography. mTBI induced anxiety-like behavior without locomotor impairment. Biochemical analyses revealed region-dependent lipid alteration predominantly in the ipsilateral hippocampus, characterized by reduced diacylglycerol and monoacylglycerol levels alongside increased total phospholipids and specific subclasses. Correlation analyses demonstrated significant associations between anxiety-related behavioral parameters and lipid classes across tissues. These findings indicate that mild TBI is accompanied by early, region-specific lipid alterations that are associated with behavioral changes during the acute post-injury period.
    Keywords:  Anxiety; Lipids; Metabolism; Trauma brain injury
    DOI:  https://doi.org/10.1007/s11010-026-05677-w
  62. Angiogenesis. 2026 Aug 12. pii: 58. [Epub ahead of print]29(4):
      Pathological choroidal neovascularization underlies vision loss in neovascular age-related macular degeneration (nAMD), yet the molecular regulators coordinating vascular and immune components remain incompletely defined. Here, we investigated the role of the endolysosomal cation channel, two-pore channel 2 (TPC2) in choroidal angiogenesis. Loss of TPC2 in mice markedly reduced ex vivo choroidal sprouting, while pharmacological activation enhanced vascular growth. Mechanistically, Tpc2-deficiency led to downregulation of multiple microglia-derived pro-angiogenic factors and impaired the ability of the microglial secretome to stimulate neovascularization. In choroidal vascular cells, TPC2 loss attenuated NF-κB/MAPK signaling pathways. Tpc2-deficiency is also associated with lysosomal secretion of cathepsins, especially CTSD, resulting in decreased extracellular proteolytic activity and impaired paracrine regulation of angiogenesis. Extending these findings to human cells, TPC2 knockout in iPSC-derived endothelial cells impaired migration, tube formation, and CTSD activity in the secretome, mirroring the murine phenotype. Together, these results establish TPC2 as one of the regulators of lysosome-mediated choroidal angiogenesis, highlighting its potential as a therapeutic target in nAMD.
    Keywords:  Cathepsins; Choroidal neovascularization; Lysosome; Microglia; TPC2
    DOI:  https://doi.org/10.1007/s10456-026-10082-4
  63. Nat Cell Biol. 2026 Aug 10.
      Exceptionally long genes and cis-regulatory enhancers are selectively activated in mammalian brain neurons, and these loci are mutation hotspots in neurological disorders. However, the organization of these large genomic elements at the level of chromosome folding, beyond local enhancer-promoter interactions, remains poorly understood. Here we report the discovery of a genomic subcompartment in the mouse cerebellum formed by near-megabase-long enhancers and their associated long genes encoding synaptic or signalling proteins. Genomic regions within this subcompartment are enriched in the outer half of the nucleus, whereas other transcriptionally active structures are enriched in the nuclear interior. Using an in vivo CRISPR genetic mini screen, we uncover a specific role for the transcription factor Etv1 in coupling the compartmentalization of neuronal long genes with their expression. Together, our study defines mechanisms that organize transcriptionally active genes across chromosomes in the mammalian brain.
    DOI:  https://doi.org/10.1038/s41556-026-02043-2
  64. Cell Rep. 2026 Aug 14. pii: S2211-1247(26)00937-X. [Epub ahead of print]45(8): 117859
      The choroid plexus (ChP) regulates cerebrospinal fluid homeostasis and immune surveillance, but its cellular organization and response to Alzheimer's disease (AD) remain incompletely defined. Here, we integrate single-nucleus RNA sequencing with spatial transcriptomics to generate a high-resolution atlas of the adult human ChP. We identify all major epithelial, stromal, and immune populations and resolve heterogeneity within macrophages, including a distinct subset expressing the giant protein TTN. These TTN+ macrophages exhibit coordinated cytoskeletal, stress-response, and phagocytic gene programs and localize to perivascular and stromal niches. In AD, we observe broad, cell type-specific transcriptional remodeling across epithelial, endothelial, mesenchymal, and immune compartments, with expansion of TTN+ macrophages and increased senescence signatures. Spatial and ligand-receptor analyses reveal altered tissue organization and macrophage interaction patterns with neighboring cells. Combined with in situ validations, these findings provide evidence of TTN expression by macrophages, and reveal a broader AD-associated contextual shift in human ChP immune function in which TTN+ macrophages are enriched.
    Keywords:  Alzheimer’s disease; CP: neuroscience; border-associated macrophages; choroid plexus; mechanobiology; single-nucleus RNA sequencing; spatial transcriptomics; titin (TTN)
    DOI:  https://doi.org/10.1016/j.celrep.2026.117859
  65. Adv Sci (Weinh). 2026 Aug 11. e77071
      Neuropathic pain is frequently comorbid with anxiety and depression, yet the mechanisms linking immune signaling to affective brain circuits remain poorly understood. Here, we identify a neuroimmune circuit in which peripheral nerve injury activates microglia in the midbrain ventrolateral periaqueductal gray/dorsal raphe (vlPAG/DRN), triggering an NLRP3-IL-1β-dependent inflammatory cascade. Direct optogenetic or chemogenetic activation of vlPAG/DRN microglia is sufficient to drive negative affective behaviors. We show that local VGLUT2+ glutamatergic neurons (vlPAG/DRNGlu) are the principal IL-1R1-expressing targets; IL-1β activates these neurons to drive anxiety- and depression-like states. Conversely, microglia-specific Nlrp3 deletion or local IL-1R1 blockade prevents neuropathic pain-induced affective deficits. Furthermore, circuit mapping and functional manipulation reveal an excitatory vlPAG/DRNGlu to the bed nucleus of the stria terminalis (BNSTGABA) pathway that is both sufficient to induce and required to maintain the affective component of neuropathic pain. Together, our findings delineate a microglia-vlPAG/DRNGlu-BNSTGABA axis that translates peripheral injury into maladaptive emotional states, revealing a discrete neuroimmune circuit substrate for mood comorbidity in chronic pain.
    Keywords:  biology; chemistry; medicine
    DOI:  https://doi.org/10.1002/advs.77071
  66. J Neuroinflammation. 2026 Aug 12. pii: 270. [Epub ahead of print]23(1):
       BACKGROUND: NLRC5 is a known activator of MHC class I genes and a regulator of type I interferon activity. Although its expression increases in brains infected with Japanese encephalitis virus (JEV), its specific contribution to JEV pathogenesis and neuroinflammation remains unclear.
    METHODS: We utilised in vitro cell cultures, in silico modelling, and in vivo mouse knockdown models of NLRC5 to investigate its impact on JEV replication, antiviral immune responses, central nervous system (CNS) inflammation, and overall disease progression.
    RESULTS: JEV infection upregulated NLRC5 expression in the brain, microglia, and non-neuronal cells, but not in neuronal cells. However, NLRC5 expression could be induced in neuroblastoma cells via IFN-γ treatment. Experimental modulation demonstrated that the typical antiviral restriction of JEV replication by IFN-γ is lost in NLRC5-deficient cells. Evaluation of stable cell lines expressing different NLRC5 variants showed that cytoplasmic retention and NLRC5 leucine-rich repeats (LRRs) are essential for viral restriction. Mechanistically, in silico modelling, co-immunoprecipitation, and immunofluorescence confirmed that NLRC5 binds directly to the viral NS3 protein in an LRR-dependent manner. In mouse models, in vivo knockdown of NLRC5 in the brain significantly accelerated clinical disease progression, heightened mortality, and triggered uncontrolled viral replication, indicated by elevated viral titers and NS3/NS1 expression. This viral surge induced severe neuroinflammation, as evidenced by significantly elevated levels of ASC and cleaved caspase-3 in NLRC5-deficient brains.
    CONCLUSIONS: These findings demonstrate that NLRC5 functions as a cell-type-specific antiviral regulator during JEV infection. It suppresses viral replication by directly binding to and degrading the viral NS3 protein. Loss of NLRC5 impairs IFN-γ-mediated antiviral restriction, leading to enhanced viral replication, severe neuroinflammation, and accelerated disease progression in vivo.
    Keywords:  IFN-γ; JEV; NLRC5; Neuroinflammation; Neuronal cells
    DOI:  https://doi.org/10.1186/s12974-026-04001-z
  67. Cell Rep. 2026 Aug 12. pii: S2211-1247(26)00911-3. [Epub ahead of print]45(8): 117833
      Chitin, a widespread environmental particle constituent, triggers lung inflammation but is degraded by chitinases. In humans, single-nucleotide polymorphisms (SNPs) in CHIA (acidic mammalian chitinase; AMCase) are associated with lung disease, suggesting that chitinase variants influence responses to airborne particles. Here, we edit the mouse Chia1 locus to generate humanized (hChia) mice harboring common human SNPs. Compared with controls expressing disease-protective SNPs, hChia mice lack robust chitinase activity and fail to degrade natural chitin substrates. Lung-resident lymphocytes and macrophages are spontaneously primed and sensitive to inflammatory triggering by environmental chitin. Immune cell infiltration correlates with airway chitin following challenge, and hChia mice exhibit exacerbated inflammatory and fibrotic lung disease. In humans with acute respiratory failure, alveolar hemorrhage coincides with environmentally derived chitin particles that are susceptible to chitinase degradation, attenuating inflammatory cell responses. Thus, environmental chitin and chitinase activity are crucial determinants of lung immune conditioning with potential therapeutic applications.
    Keywords:  AMCase; CHIA; CP: genomics; CP: immunology; IL-1β signaling; alveolar macrophages; chitin; chitinase; gene-environment interaction; immune conditioning; lung inflammation; pulmonary fibrosis
    DOI:  https://doi.org/10.1016/j.celrep.2026.117833
  68. Proc Natl Acad Sci U S A. 2026 08 18. 123(33): e2600696123
      The role of lipid droplets (LDs), typically regarded as storage sites for neutral lipid, in plant defense remains poorly understood. In our study with barley stripe mosaic virus (BSMV), a (+)ssRNA virus, we found that infection significantly increases LD abundance in Nicotiana benthamiana and wheat. Using split-TurboID-based proximity labeling, we identified LD-associated proteins (LDAPs) at ER-chloroplast contact sites. Increasing LD formation by overexpressing mouse FIT2 or plant NbLDAP2.1 decreased viral accumulation, whereas impairing LD formation led to higher infection. Live cell imaging and genetic studies revealed that LDs move along actin filaments, cluster around chloroplasts, and contribute to antiviral immunity through a salicylic acid (SA)-dependent mechanism. Moreover, LDs conferred resistance to multiple (+)ssRNA viruses in N. benthamiana and a (-)ssRNA virus in rice. These findings uncover a role for LDs in SA-dependent antiviral defense that does not compromise growth, offering potential approaches for engineering virus-resistant crops.
    Keywords:  LD-associated proteins 2.1; barley stripe mosaic virus; defense; lipid droplets; salicylic acid
    DOI:  https://doi.org/10.1073/pnas.2600696123
  69. Sci Adv. 2026 Aug 14. 12(33): eaef9926
      Human surgery and autopsy specimens are routinely stored as formalin-fixed paraffin-embedded (FFPE) tissue blocks for decades, creating vast archives of healthy and diseased tissues. While tissue clearing and whole-mount microscopy enable 3D analysis, FFPE human tissue blocks are often unsuitable for clearing and immunolabeling due to their large size and extensive cross-linking. Here, we introduce "archival" DISCO (aDISCO), a clearing method designed to overcome these challenges. aDISCO achieves effective clearing and immunolabeling of large samples stored for 15 years or more. We applied aDISCO to human brain, spinal cord, peripheral nerve, skin, muscle, heart, kidney, liver, spleen, colon, and lung, using a broad range of antibodies. Combining aDISCO with deep learning-based analysis to study focal cortical dysplasia (FCD), we found disrupted cortical layering with both focal and global neuronal density variations, features likely to be overlooked by conventional histology. In summary, aDISCO delivers datasets suitable for deep learning-based processing, enabling the detection of subtle and sparse pathologies in large archival human tissue specimens.
    DOI:  https://doi.org/10.1126/sciadv.aef9926
  70. Mol Ther Nucleic Acids. 2026 Sep 08. 37(3): 103012
      Efficient brain gene editing remains constrained by the lack of delivery platforms that combine efficacy, spatial precision, and translational potential. Compared with viral vectors, lipid nanoparticles (LNPs) offer larger cargo capacity and lower immunogenicity for repeat dosing. However, their brain delivery is restricted by the blood-brain barrier (BBB). Here, we show that focused ultrasound (FUS)-mediated BBB opening enables systemic delivery of CRISPR-encoding plasmid DNA (pDNA)-LNPs for brain gene editing. Using a pDNA construct containing astrocyte-targeting GfaABC1D promoter and dual guide RNAs targeting apolipoprotein E4 (APOE4), the strongest genetic risk factor for Alzheimer's disease, we achieved efficient APOE4 knockdown, with reduced APOE4 mRNA and apoE4 protein expression, and attenuated astrocytes and microglial activation. These results establish FUS-mediated pDNA-LNP delivery as a non-invasive, non-viral strategy for brain gene editing that provides spatial control and cell-type-specific expression, while accommodating large genetic payload and enabling repeatable dosing.
    Keywords:  Alzheimer’s disease; MT: RNA/DNA editing; focused ultrasound; gene delivery; gene editing; lipid nanoparticles; non-viral gene therapy
    DOI:  https://doi.org/10.1016/j.omtn.2026.103012
  71. Nature. 2026 Aug;656(8127): 286-289
      
    Keywords:  Alzheimer's disease; Brain; Health care; Medical research
    DOI:  https://doi.org/10.1038/d41586-026-02448-x
  72. Int Rev Neurobiol. 2026 ;pii: S0074-7742(26)00039-5. [Epub ahead of print]188 397-434
      Metabolic dysregulation has emerged as a crucial pathogenic factor that contributes in progression of Alzheimer's disease (AD), and is often found to precede classical AD's pathologies, the amyloid-β accumulation and hyperphosphorylated tau proteinopathies. The key metabolic underpinnings associated with Alzheimer's disease (AD) includes cerebral glucose hypometabolism, insulin resistance, mitochondrial dysfunction, altered lipid metabolism, vascular and systemic metabolic impairments, disrupted amino acid and nitrogen metabolism driving secondary metabolic disturbances. The chapter outlines the current evidences on dysregulated metabolic processes, and highlights emerging metabolic biomarkers that are identified through advanced neuroimaging modalities, plasma/cerebrospinal fluid (CSF) profiles, lipidomic signatures and markers of mitochondrial impairment, underscoring their diagnostic and prognostic potential. Furthermore, the chapter discusses about the therapeutic prospects targeting metabolic pathways, addressing current challenges in development of therapeutic strategies, reinforcing the need for integrative and precision-based interventions for early diagnosis and disease modifying therapeutic strategies in AD.
    Keywords:  Alzheimer’s disease (AD); Amyloid-β; Glucose hypometabolism; Metabolic biomarkers; Mitochondrial dysfunction; Neuroinflammation
    DOI:  https://doi.org/10.1016/bs.irn.2026.05.011
  73. Cell. 2026 Aug 04. pii: S0092-8674(26)00806-8. [Epub ahead of print]
      Cognitive manifestations, including impairments in language and executive functions, are seen in amyotrophic lateral sclerosis (ALS), but the underlying mechanisms remain unclear. We mapped prefrontal cortex regions from ALS patients by integrating spatial and single-nucleus transcriptomics in a cognitively stratified patient cohort. We uncover that cognitive impairment in ALS is associated with distinct patterns of neuronal dysfunction and glial-vascular dysregulation that vary by region and cognitive subtype. Executive dysfunction is linked to reduced mitochondrial and synaptic activity in deep-layer dorsolateral prefrontal cortex neurons, whereas language-related deficits track with a diffuse pan-regional response involving glial and vascular abnormalities. Our analyses, validated by multiplexed imaging, further identify signatures in the prefrontal cortex that span both motor and cognitive phenotypes, including a multicellular gliosis response. The findings reveal that clinical heterogeneity in ALS is driven by phenotype-specific cellular interactions in motor and non-motor regions of the brain.
    Keywords:  ALS; ALS-FTD; ALS-FTSD; cognitive heterogeneity; cognitive impairment in ALS; executive function; language; multimodal analysis; spatial biology; verbal fluency
    DOI:  https://doi.org/10.1016/j.cell.2026.07.008
  74. Alzheimers Dement. 2026 Aug;22(8): e71720
       INTRODUCTION: Blood-brain barrier (BBB) dysfunction is an early feature of Alzheimer's disease (AD). Fibrinogen represents a sensitive marker of BBB leakage, but whether it modifies longitudinal tau progression in cognitively unimpaired (CU) individuals remains unknown.
    METHODS: CU older adults underwent clinical evaluation and cerebrospinal fluid (CSF) assessment of fibrinogen, Aβ42, total tau (tTau), phosphorylated tau 181 (pTau181), and YKL-40. Linear regression tested baseline associations. Linear mixed-effects models tested whether baseline fibrinogen predicted longitudinal pTau181 change.
    RESULTS: Among 169 CU participants with baseline fibrinogen, 87 had longitudinal pTau181 measurements (mean follow-up 2.5-years). Higher fibrinogen was associated with elevated YKL-40 (β = 0.28, 95% confidence interval [CI] [0.11, 0.45]) but not Aβ42, tTau, or pTau181 at baseline. Baseline fibrinogen modified longitudinal pTau181 trajectories (interaction β = 0.11, 95% CI [0.04, 0.19]), with only participants above the median showing significant pTau181 increases (β = 0.13, 95% CI [0.08, 0.18]).
    DISCUSSION: CSF fibrinogen associates cross-sectionally with glial inflammation and predicts accelerated tau accumulation in preclinical AD.
    Keywords:  biomarkers; neuroinflammation; neurovascular integrity; preclinical neurodegeneration
    DOI:  https://doi.org/10.1002/alz.71720
  75. Cell Host Microbe. 2026 Aug 10. pii: S1931-3128(26)00310-0. [Epub ahead of print]
      Effector-triggered immunity (ETI) is central in plant defense, but whether all cell types execute ETI similarly remains unknown. We combined chemically imposed immune activation with single-cell transcriptomics to profile ETI responses across major leaf cell types in Arabidopsis. Despite uniform ETI perception, we find divergent transcriptional outputs: a core set of defense genes is broadly induced, while distinct cell types activate specialized immune modules. We infer that immune outputs are shaped not only by immune receptor activation but also by cell identity, transcription factor availability, and chromatin accessibility. We further demonstrate that epidermis-enriched transcriptional regulators are required to restrict invasion by non-adapted pathogens. Their absence permits pathogen entry into deeper tissues despite intact recognition, revealing a spatial division of immune functions. Our findings uncover a layered immune architecture in plants, challenge the assumption of uniform immune activation, and establish a framework for exploring cell-type-specific resistance logic in multicellular hosts.
    Keywords:  ETI; cell-autonomous immunity; cell-type-specific immunity; effector-triggered immunity; single-cell RNA sequencing; transcriptional regulation
    DOI:  https://doi.org/10.1016/j.chom.2026.07.009
  76. Elife. 2026 Aug 14. pii: RP93640. [Epub ahead of print]13
      Chimerism happens rarely among most mammals, but is common in marmosets and tamarins, a result of fraternal twin or triplet birth patterns in which in utero connected circulatory systems (through which stem cells transit) lead to persistent blood chimerism (12-80%) throughout life. The presence of Y-chromosome DNA sequences in organs of female marmosets has long suggested that chimerism might also affect these organs. However, a longstanding question is whether this chimerism is driven by blood-derived cells or involves contributions from other cell types. To address this question, we analyzed single-cell RNA-seq data from blood, liver, kidney, and many brain regions across a number of marmosets, using transcribed single-nucleotide polymorphisms (SNPs) to identify cells with the sibling's genome in various cell types within these tissues. Sibling-derived chimerism in all tissues arose entirely from cells of hematopoietic origin (i.e., myeloid and lymphoid lineages). In brain tissue this was reflected as sibling-derived chimerism among microglia (20-52%) and macrophages (18-64%) but not among other resident cell types (neurons, glia, or ependymal cells). The percentage of microglia that were sibling-derived showed significant variation across brain regions, even within individual animals, likely reflecting distinct responses by genetic-sibling microglia to local recruitment or proliferation cues or, potentially, distinct clonal expansion histories in different brain areas. In the animals and tissues we analyzed, microglial gene expression profiles bore a much stronger relationship to local/host context than to sibling genetic differences. Naturally occurring marmoset chimerism will provide new ways to recognize the effects of genes, mutations, and brain contexts on microglial biology and to distinguish between effects of microglia and other cell types on brain phenotypes.
    Keywords:  Callithrix jacchus; genetics; genomics; marmosets; microglia; sibling chimerism
    DOI:  https://doi.org/10.7554/eLife.93640